# EDGAR Filing Document

**Accession Number:** 0001159152
**File Stem:** 0001159152-26-000015
**Filing Date:** 2026-2
**Character Count:** 262648
**Document Hash:** d47076ebf1e9d22f9d9594a9a18501d1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001159152-26-000015.hdr.sgml**: 20260211

**ACCESSION NUMBER**: 0001159152-26-000015

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 42

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260211

**DATE AS OF CHANGE**: 20260210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** James Hardie Industries plc
- **CENTRAL INDEX KEY:** 0001159152
- **STANDARD INDUSTRIAL CLASSIFICATION:** CONCRETE PRODUCTS, EXCEPT BLOCK & BRICK [3272]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15240
- **FILM NUMBER:** 26617594

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1ST FLOOR, BLOCK A
- **STREET 2:** ONE PARK PLACE, UPPER HATCH STREET
- **CITY:** DUBLIN 2
- **PROVINCE COUNTRY:** L2
- **ZIP:** D02 FD79
- **BUSINESS PHONE:** 353 1411 6924

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1ST FLOOR, BLOCK A
- **STREET 2:** ONE PARK PLACE, UPPER HATCH STREET
- **CITY:** DUBLIN 2
- **PROVINCE COUNTRY:** L2
- **ZIP:** D02 FD79

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JAMES HARDIE INDUSTRIES SE
- **DATE OF NAME CHANGE:** 20100219

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JAMES HARDIE INDUSTRIES N.V.
- **DATE OF NAME CHANGE:** 20090508

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HARDIE JAMES INDUSTRIES NV
- **DATE OF NAME CHANGE:** 20010914

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 6-K**

**Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16**

**under the Securities Exchange Act of 1934**

For the Month of February 2026

1-15240

(Commission File Number)

**JAMES HARDIE INDUSTRIES plc**

(Translation of registrant's name into English)

1st Floor, Block A,

One Park Place

Upper Hatch Street, Dublin 2, D02, FD79, Ireland

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F..X.... Form 40-F.........

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Not Applicable

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Not Applicable

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

**<u>**TABLE OF CONTENTS**</u>**

---

| | |
|:---|:---|
| <u>[Forward-Looking Statements](#id7d023b3efab44719ea20712d9bc1720_7)</u> | 3 |
| <u>[Exhibit Index](#id7d023b3efab44719ea20712d9bc1720_10)</u> | 5 |
| <u>[Signatures](#id7d023b3efab44719ea20712d9bc1720_13)</u> | 6 |

---

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

*Forward-Looking Statements*

This Form 6-K contains forward-looking statements. James Hardie Industries plc (the "Company") may from time to time make forward-looking statements in its periodic reports filed with or furnished to the Securities and Exchange Commission, on Forms 20-F and 6-K, in its annual reports to shareholders, in offering circulars, invitation memoranda and prospectuses, in media and earnings releases and other written materials and in oral statements made by the Company's officers, directors or employees to analysts, institutional investors, existing and potential lenders, representatives of the media and others. Statements that are not historical facts are forward-looking statements and such forward-looking statements are statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

Examples of forward-looking statements include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements about the future integration of AZEK, including its anticipated benefits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements about the Company's future performance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• projections of the Company's results of operations or financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements regarding the Company's plans, objectives or goals, including those relating to strategies, initiatives, competition, acquisitions, dispositions and/or its products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expectations concerning the costs associated with the suspension or closure of operations at any of the Company's plants and future plans with respect to any such plants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expectations concerning the costs associated with the significant capital expenditure projects at any of the Company's plants and future plans with respect to any such projects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expectations regarding the extension or renewal of the Company's credit facilities including changes to terms, covenants or ratios;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expectations concerning dividend payments and share buy-backs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements concerning the Company's Corporate and tax domiciles and structures and potential changes to them, including potential tax charges;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements regarding tax liabilities and related audits, reviews and proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements regarding the possible consequences and/or potential outcome of legal proceedings brought against us and the potential liabilities, if any, associated with such proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expectations about the timing and amount of contributions to AICF, a special purpose fund for the compensation of proven Australian asbestos-related personal injury and death claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements regarding the Company's ability to manage legal and regulatory matters (including but not limited to product liability, environmental, intellectual property and competition law matters) and to resolve any such pending legal and regulatory matters within current estimates and in anticipation of certain third-party recoveries; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• statements about economic or housing market conditions in the regions in which we operate, including but not limited to, the levels of new home construction and home renovations, unemployment levels, changes in consumer income, changes or stability in housing values, the availability of mortgages and other financing, mortgage and other interest rates, housing affordability and supply, the levels of foreclosures and home resales, currency exchange rates, and builder and consumer confidence.

Words such as "believe," "anticipate," "plan," "expect," "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "aim," "will," "should," "likely," "continue," "may," "objective," "outlook" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Readers are cautioned not to place undue reliance on these forward-looking statements and all such forward-looking statements are qualified in their entirety by reference to the following cautionary statements.

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

Forward-looking statements are based on the Company's current expectations, estimates and assumptions and because forward-looking statements address future results, events and conditions, they, by their very nature, involve inherent risks and uncertainties, many of which are unforeseeable and beyond the Company's control. Such known and unknown risks, uncertainties and other factors may cause actual results, performance or other achievements to differ materially from the anticipated results, performance or achievements expressed, projected or implied by these forward-looking statements. These factors, some of which are discussed under "Risk Factors" in Section 3 of our Form 20-F filed with the Securities and Exchange Commission on 20 May 2025, include, but are not limited to: all matters relating to or arising out of the prior manufacture of products that contained asbestos by current and former Company subsidiaries; required contributions to AICF, any shortfall in AICF funding and the effect of currency exchange rate movements on the amount recorded in the Company's financial statements as an asbestos liability; compliance with and changes in tax laws and treatments; competition and product pricing in the markets in which the Company operates; the consequences of product failures or defects; exposure to environmental, asbestos, putative consumer class action or other legal proceedings; general economic and market conditions; the supply and cost of raw materials; possible increases in competition and the potential that competitors could copy the Company's products; compliance with and changes in environmental and health and safety laws; risks of conducting business internationally; compliance with and changes in laws and regulations; currency exchange risks; dependence on customer preference and the concentration of the Company's customer base; dependence on residential and commercial construction markets; the effect of adverse changes in climate or weather patterns; use of accounting estimates; the AZEK acquisition; and all other risks identified in the Company's reports filed with Australian, Irish and US securities regulatory agencies and exchanges (as appropriate). The Company cautions you that the foregoing list of factors is not exhaustive and that other risks and uncertainties may cause actual results to differ materially from those referenced in the Company's forward-looking statements. Forward-looking statements speak only as of the date they are made and are statements of the Company's current expectations concerning future results, events and conditions. The Company assumes no obligation to update any forward-looking statements or information except as required by law.

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[99.1](ex991resultsq3fy26.htm)</u> | Results for Announcement to the Market |
| <u>[99.2](ex992erq3fy26.htm)</u> | Earnings Release |
| <u>[99.3](ex993maq3fy26.htm)</u> | Management's Analysis of Results |
| <u>[99.4](fy26q3earningspresentati.htm)</u> | Earnings Presentation |
| <u>[99.5](ex995fpagesq3fy26.htm)</u> | Condensed Consolidated Financial Statements |
| <u>[99.6](ex996statementofcdisonis.htm)</u> | Statement of CDIs on issue - JHX |
| <u>[99.7](ex997notificationregardi.htm)</u> | Notification regarding unquoted securities - JHX |
| <u>[99.8](ex998notificationregardi.htm)</u> | Notification regarding unquoted securities - JHX |

---

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| | **James Hardie Industries plc** |
| Date: 11 February 2026 | By: /s/ Aoife Rockett |
|  | Aoife Rockett |
|  | Company Secretary |

---

------

<u>[**Table of Contents**](#id7d023b3efab44719ea20712d9bc1720_4)</u>

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[99.1](ex991resultsq3fy26.htm)</u> | Results for Announcement to the Market |
| <u>[99.2](ex992erq3fy26.htm)</u> | Earnings Release |
| <u>[99.3](ex993maq3fy26.htm)</u> | Management's Analysis of Results |
| <u>[99.4](fy26q3earningspresentati.htm)</u> | Earnings Presentation |
| <u>[99.5](ex995fpagesq3fy26.htm)</u> | Condensed Consolidated Financial Statements |
| <u>[99.6](ex996statementofcdisonis.htm)</u> | Statement of CDIs on issue - JHX |
| <u>[99.7](ex997notificationregardi.htm)</u> | Notification regarding unquoted securities - JHX |
| <u>[99.8](ex998notificationregardi.htm)</u> | Notification regarding unquoted securities - JHX |

---

## Exhibit 99.1

**Exhibit 99.1**

![logo_1.jpg](logo_1.jpg)

**James Hardie Industries plc**<br>1st Floor, Block A<br>One Park Place<br>Upper Hatch Street, Dublin 2<br>D02 FD79, Ireland <br>T: +353 (0) 1 411 6924<br>F: +353 (0) 1 479 1128<br>

11 February 2026

The Manager

Company Announcements Office

Australian Securities Exchange Limited

20 Bridge Street

SYDNEY NSW 2000

Dear Sir/Madam

**Results for Announcement to the Market**

James Hardie announced today its results for the 3rd quarter and nine months ended 31 December 2025 and has filed the following documents with the ASX:

•  Earnings Release

•  Management's Analysis of Results

•  Earnings Presentation

•  Condensed Consolidated Financial Statements

Copies of these documents are available on James Hardie's investor relations website at <br><u>https://ir.jameshardie.com.au/</u><u>financial-information/financial-results</u>.

---

| |
|:---|
| Yours faithfully |
| Aoife Rockett |
| Company Secretary |

---

*This announcement has been authorized for release by the Board of Directors of James Hardie Industries plc.*

  

James Hardie Industries plc is a limited liability company incorporated in Ireland with its registered office at<br>1<sup>st</sup> Floor, Block A, One Park Place, Upper Hatch Street, Dublin 2, D02 FD79, Ireland.

**Directors:** Nigel Stein (UK) (Chair), Howard Heckes (USA), Gary Hendrickson (USA), Persio Lisboa (USA),<br>Renee Peterson (USA), John Pfeifer (USA), Suzanne B. Rowland (USA), Jesse Singh (USA).

**Chief Executive Officer and Director:** Aaron Erter (USA)

**Company number**: 485719

**ARBN:** 097 829 895

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 99.2

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Exhibit 99.2**

**James Hardie Reports Third Quarter FY26 Results** 

**Q3 FY26 Net Sales of $1.2 Billion, Up +30% with Organic Net Sales +1%**

**Operating Income of $176 Million, Adjusted EBITDA of $330 Million**

**Siding & Trim Net Sales Up +10% with Organic Net Sales Down (2%)**

**~500 Basis Points of Sequential Siding & Trim Adjusted EBITDA Margin Expansion**

**Deck, Rail & Accessories Net Sales Up +2% with Sell-Through Up Mid-Single-Digits** <sup>1</sup>

**Integration and Cost Synergies Ahead of Schedule, Focused on the Achievement of $125 Million Target**

**James Hardie Industries plc (NYSE / ASX : JHX) ("James Hardie" or the "Company")**, a leading provider of exterior home and outdoor living solutions, today announced results for its third quarter ending December 31, 2025.

Aaron Erter, CEO of James Hardie said, "In the third-quarter, we achieved or exceeded each of our financial commitments despite a mixed macro backdrop. We are taking actions to address the current market environment, including optimizing our manufacturing footprint and better aligning our cost structure with the slower, but stabilizing, pace of demand. These actions will improve near-term profitability and better position the Company to profitably grow when conditions improve.

Siding & Trim organic net sales were down modestly in the quarter, while Adjusted EBITDA margin improved nearly 500 basis points sequentially primarily driven by price / mix favorability and our actions to drive Hardie Operating System savings. Deck, Rail & Accessories delivered mid-single-digit sell-through growth, demonstrating our ability to drive material conversion through channel expansion and new product initiatives."

Mr. Erter continued, "Our confidence in the combination of James Hardie and AZEK continues to be strong as customers respond to our differentiated products, leading brands, focus on innovation and investment across the value chain. We continue to make progress on the integration and have surpassed our FY26 cost synergy goal. Our progress to date reaffirms our confidence in hitting our $125 million cost synergy target. On the commercial front, our early wins with dealers, contractors and homebuilders will drive meaningful revenue synergies in FY27 and beyond, demonstrating our potential to accelerate material conversion across exteriors and outdoor living."

Note:<sup>1</sup>All Deck, Rail & Accessories growth comparisons correspond to the quarter ended December 31, 2024, prior to the acquisition of AZEK by James Hardie, unless otherwise stated.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>1</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Consolidated Financial Information**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Q3 FY26** | **Q3 FY25** | **Change** | **9 Months<br>FY26** | **9 Months<br>FY25** | **Change** |
| **Group** | **(US$ millions, except per share data)** | **(US$ millions, except per share data)** | **(US$ millions, except per share data)** | **(US$ millions, except per share data)** | **(US$ millions, except per share data)** | **(US$ millions, except per share data)** |
| Net Sales | 1239.8 | 953.3 | +30% | 3431.9 | 2906.0 | +18% |
| Operating Income | 176.2 | 206.1 | (15%) | 338.8 | 593.8 | (43%) |
| Operating Income Margin | 14.2% | 21.6% | (740bps) | 9.9% | 20.4% | (1,050bps) |
| Adjusted EBITDA | 329.9 | 262.1 | +26% | 884.9 | 810.8 | +9% |
| Adjusted EBITDA Margin | 26.6% | 27.5% | (90bps) | 25.8% | 27.9% | (210bps) |
| Net Income | 68.7 | 141.7 | (52%) | 75.5 | 380.4 | (80%) |
| Adjusted Net Income | 142.2 | 153.6 | (7%) | 423.1 | 488.2 | (13%) |
| Diluted EPS - US$ per share | 0.12 | 0.33 | (64%) | 0.14 | 0.88 | (84%) |
| Adjusted Diluted EPS - US$ per share | 0.24 | 0.36 | (31%) | 0.79 | 1.13 | (30%) |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>2</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Segment Business Update and Results**<br>

<u>Siding & Trim</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Q3 FY26** | **Q3 FY25** | **Change** | **9 Months<br>FY26** | **9 Months<br>FY25** | **Change** |
| **Siding & Trim** | **(US$ millions)** | **(US$ millions)** | **(US$ millions)** | **(US$ millions)** | **(US$ millions)** | **(US$ millions)** |
| Net Sales | 788.3 | 719.3 | +10% | 2196.1 | 2144.4 | 2% |
| Operating Income | 202.9 | 209.3 | (3%) | 515.1 | 638.5 | (19%) |
| Operating Income Margin | 25.7% | 29.1% | (340bps) | 23.5% | 29.8% | (630bps) |
| Adjusted EBITDA | 268.6 | 250.5 | +7% | 698.4 | 754.0 | (7%) |
| Adjusted EBITDA Margin | 34.1% | 34.8% | (70bps) | 31.8% | 35.2% | (340bps) |

---

Net sales increased 10% due to the inorganic net sales contribution from AZEK Exteriors. On an organic basis, net sales declined (2%) with an increase in average net sales price more than offset by lower volumes driven by soft market demand. Volume of Exterior products declined mid-single-digits, with Single-Family down high-single-digits and Multi-Family up high-single-digits, while volume of Interior products declined double-digits. The Single-Family Exteriors decline was primarily due to a weaker new construction environment across the South, where James Hardie has built strong leadership positions with large homebuilders in key long-term growth markets such as Texas, Florida and Georgia. Housing markets in these geographies have been especially impacted by affordability challenges and elevated housing inventory. While Adjusted EBITDA margin improved 490bps sequentially, adjusted EBITDA margin decreased (70bps) year-over-year to 34.1%, due to unfavorable production cost absorption and higher freight and raw material costs, and the allocation of certain R&D expenses which were not allocated to the segment in the prior year, partially offset by a higher average net sales price and Hardie Operating System (HOS) savings.

In Siding & Trim, we are focused on returning the segment to organic growth through four core growth strategies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.**<u>R&R Focus:</u>** We are increasing our focus on repair & remodel, particularly in the Northeast and Midwest, where we see $1 billion material conversion opportunity in wood- and wood-look siding products

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.**<u>Deeper New Construction Penetration:</u>** We are expanding on our strong large builder relationships and seeking growth with custom and local builders where there is $750 million of opportunity for additional growth

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.**<u>Product Innovation:</u>** We are focused on new product innovation in Siding, including differentiated offerings, to support our long-term growth

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.**<u>Installation Efficiency:</u>** We are partnering with our contractors and installers to introduce innovative installation techniques to reduce time and installed costs, expanding the total addressable market for fiber cement

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>3</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

<u>Deck, Rail & Accessories (DR&A)</u>

---

| | | |
|:---|:---|:---|
| | **Q3 FY26** | **9 Months<br>FY26** |
| **Deck, Rail & Accessories** | **(US$ millions)** | **(US$ millions)** |
| Net Sales | 194.1 | 449.9 |
| Operating Loss | (24.0) | (35.9) |
| Operating Loss Margin  | (12.4%) | (8.0%) |
| Adjusted EBITDA | 48.7 | 127.3 |
| Adjusted EBITDA Margin | 25.1% | 28.3% |

---

Deck, Rail & Accessories net sales increased +2% compared to the quarter ended December 31, 2024 prior to the acquisition driven primarily by price / mix. Sell-through was up mid-single-digits, consistent with growth in the prior quarter. Adjusted EBITDA margin was 25.1% reflecting the benefit of top-line growth, partially offset by growth investments. In addition to cost synergies, the runway for margin improvement in Deck, Rail & Accessories is enabled by recycling initiatives, improved absorption across the manufacturing network, and leveraging the Hardie Operating System.

In Deck, Rail & Accessories, the organic strategy remains consistent with a focus on continued channel expansion and new product launches. Last calendar year's new product launches have been well received by customers, and additional new offerings are being launched in early 2026 which strengthen TimberTech's commitment to combining superior aesthetics with advanced functionality for both homeowners and contractors alike. Additionally, the combination with James Hardie has helped to accelerate growth and secure incremental shelf space at dealer partners throughout early buy negotiations as customers recognize the enhanced value proposition delivered through a comprehensive product portfolio, trusted brands and long-term partnerships.

<u>Australia & New Zealand (ANZ)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Q3 FY26** | **Q3 FY25** | **Change** | **9 Months<br>FY26** | **9 Months<br>FY25** | **Change** |
| **Australia & New Zealand** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** |
| Net Sales | 126.5 | 118.1 | +7% | 381.0 | 401.8 | (5%) |
| Net Sales (A$ millions) | 192.9 | 180.1 | +7% | 585.6 | 606.9 | (4%) |
| Operating Income | 35.6 | 34.8 | +2% | 111.4 | 68.0 | +64% |
| Operating Income Margin | 28.1% | 29.3% | (120bps) | 29.2% | 17.2% | +1,200bps |
| Adjusted EBITDA | 41.2 | 39.7 | +4% | 127.7 | 139.7 | (9%) |
| Adjusted EBITDA Margin | 32.6% | 33.5% | (90bps) | 33.5% | 34.7% | (120bps) |

---

Net sales increased +7%, with low-single-digit volume growth and a mid-single-digit increase in average net sales price. Adjusted EBITDA margin of 32.6% decreased (90bps) as volume and price growth and HOS savings were more than offset by unfavorable production cost absorption and the allocation of R&D costs which were not previously allocated to the reportable segments.

The Company is focused on driving growth in Australia and New Zealand through new customer acquisitions and project conversion enabled by customer collaboration and leveraging the James Hardie brand. The teams are innovating to accelerate material conversion to fiber cement with a key focus on new construction. Overall, while market demand remains challenged, the ANZ team is focused on finding further manufacturing efficiencies and driving HOS savings to underpin the segment's consistent profitability.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>4</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

<u>Europe</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Q3 FY26** | **Q3 FY25** | **Change** | **9 Months<br>FY26** | **9 Months<br>FY25** | **Change** |
| **Europe** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** | **(US$ millions, unless otherwise noted)** |
| Net Sales | 130.9 | 115.9 | +13% | 404.9 | 359.8 | +13% |
| Net Sales (€ millions) | 112.4 | 108.6 | +3% | 350.4 | 332.9 | +5% |
| Operating Income | 9.1 | 3.6 | +153% | 37.9 | 24.7 | +53% |
| Operating Income Margin | 7.0% | 3.1% | +390bps | 9.4% | 6.8% | +260bps |
| EBITDA | 16.6 | 11.9 | +39% | 59.5 | 48.6 | +22% |
| EBITDA Margin | 12.7% | 10.3% | +240bps | 14.7% | 13.5% | +120bps |

---

Net sales increased +13%, or +3% in Euros, driven by mid-single-digit volume growth. While underlying price realization remains positive, average net sales price in Euros was down modestly due to unfavorable mix shift as fiber gypsum volumes meaningfully outpaced fiber cement in the quarter. EBITDA margin increased +240bps to 12.7%, attributable to favorable plant performance, as well as lower raw material costs. Higher SG&A expense relates to increased investment in sales teams and marketing supporting growth strategies for high-value products.

Markets across Europe remain challenged, particularly in Germany, the Company's largest European market, where improvement is anticipated to be more gradual. Growth in high-value products, such as Therm25<sup>TM</sup> fiber gypsum flooring, remains a strategic priority, as leveraging a broader and deeper product portfolio should accelerate share gains and customer wins. The team's plan to expand margins is comprised of purposeful investment to drive operating leverage alongside sales growth and HOS savings from production footprint optimization and freight management.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>5</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Outlook**<br>

**FY26 Guidance**

With respect to FY26 guidance, Ryan Lada, CFO, said, "For Siding & Trim, market conditions remain challenged, consistent with our prior expectations; however, channel inventories have normalized. As a result, we are allowing our stronger-than-expected third-quarter performance to flow through to full-year results, resulting in a modest increase in the guidance range for the segment. We continue to expect the broader Exteriors market to remain mixed in the near term. For Deck, Rail & Accessories, mid-single-digit sell-through growth continued through the third quarter and into early Q4. We expect channel partner inventories to remain at seasonally normal levels for the remainder of the fiscal year."

• Net Sales for Siding & Trim: **$2.953 to $2.998 billion** (prev. $2.925 to $2.995 billion)

• Net Sales for Deck, Rail & Accessories: **$787 to $800 million** (prev. $780 to $800 million)

• Adjusted EBITDA for Siding & Trim: **$939 to $962 million** (prev. $920 to $955 million)

• Adjusted EBITDA for Deck, Rail & Accessories: **$219 to $224 million** (prev. $215 to $225 million)

• Total Adjusted EBITDA: **$1.232 to $1.263 billion** (prev. $1.20 to $1.25 billion)

• Free Cash Flow: At Least **$200 million** (unchanged)

Note: All guidance includes a partial-year contribution from the AZEK acquisition which was incorporated into James Hardie results beginning at closing on July 1, 2025. Free cash flow represents net cash provided by operating activities less purchases of property, plant and equipment net of proceeds from the sale of property, plant and equipment.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>6</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Cash Flow, Capital Investment & Allocation**<br>

Operating cash flow totaled $455 million for the nine months ended FY26, driven by net income, adjusted for non-cash items of $536 million and lower working capital of $33 million, partially offset by $87 million of asbestos claims and handling costs paid. Capital expenditures were $303 million.

Our capital expenditures program is driven by strategic investments that support long-term growth and operational excellence. These priorities include adding new capacity ahead of anticipated demand, funding new product development and other strategic initiatives, and maintaining and reinvesting in our existing facilities and equipment. For fiscal year 2026, we expect total capital expenditures of approximately $400 million, inclusive of approximately $75 million related to AZEK initiatives. Spending associated with our Global Capacity Expansion program is projected to be approximately $90 million of the fiscal year 2026 total.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>7</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Reported Financial Results**<br>

---

| | | |
|:---|:---|:---|
| (Millions of US dollars) | **(Unaudited)<br>December 31<br>2025** | March 31<br>2025 |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**344.2** | $562.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and cash equivalents | **5.0** | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and cash equivalents - Asbestos | **25.7** | 37.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted short-term investments - Asbestos | **187.3** | 175.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and other receivables, net | **311.0** | 391.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **665.8** | 347.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **160.2** | 100.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale | **11.3** | 73.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance receivable - Asbestos | **5.8** | 5.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workers' compensation - Asbestos | **2.5** | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **1718.8** | 1701.8 |
| Property, plant and equipment, net | **3095.4** | 2169.0 |
| Operating lease right-of-use-assets | **127.3** | 70.4 |
| Finance lease right-of-use-assets | **106.1** | 2.7 |
| Goodwill | **4822.0** | 193.7 |
| Intangible assets, net | **3526.9** | 145.6 |
| Insurance receivable - Asbestos | **21.5** | 23.2 |
| Workers' compensation - Asbestos | **17.5** | 16.5 |
| Deferred income taxes | **74.7** | 600.4 |
| Deferred income taxes - Asbestos | **272.1** | 284.5 |
| Other assets | **22.2** | 22.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**13804.5** | $5229.9 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $**667.2** | $446.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and employee benefits | **150.7** | 133.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | **31.6** | 21.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | **5.4** | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, current portion | **43.8** | 9.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued product warranties | **11.2** | 7.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **14.4** | 10.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos liability | **127.3** | 119.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workers' compensation - Asbestos | **2.5** | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | **59.7** | 59.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **1113.8** | 810.2 |
| Long-term debt | **4565.1** | 1110.1 |
| Deferred income taxes | **564.6** | 121.1 |
| Operating lease liabilities | **112.5** | 63.9 |
| Finance lease liabilities | **103.6** | 1.8 |
| Accrued product warranties | **42.5** | 26.9 |
| Asbestos liability | **831.5** | 864.2 |
| Workers' compensation - Asbestos | **17.5** | 16.5 |
| Other liabilities | **56.7** | 53.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | **7407.8** | 3068.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | **6396.7** | 2161.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $**13804.5** | $5229.9 |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>8</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | (Unaudited)<br>Three Months Ended December 31 | (Unaudited)<br>Three Months Ended December 31 | (Unaudited)<br>Nine Months Ended December 31 | (Unaudited)<br>Nine Months Ended December 31 |
| (Millions of US dollars, except per share data) | **2025** | 2024 | **2025** | 2024 |
| Net sales | $**1239.8** | $953.3 | $**3431.9** | $2906.0 |
| Cost of goods sold | **791.6** | 590.9 | **2225.7** | 1773.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | **448.2** | 362.4 | **1206.2** | 1132.2 |
| Selling, general and administrative expenses | **249.7** | 144.7 | **656.6** | 444.4 |
| Research and development expenses | **16.6** | 11.5 | **44.5** | 36.1 |
| Restructuring, net | **(24.0)** |  | **(24.0)** | 57.3 |
| Acquisition related expenses | **29.4** |  | **189.1** |  |
| Asbestos adjustments | **0.3** | 0.1 | **1.2** | 0.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | **176.2** | 206.1 | **338.8** | 593.8 |
| Interest, net | **65.6** | 3.8 | **168.8** | 7.4 |
| Other expense (income), net | **—** |  | **9.7** | (0.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | **110.6** | 202.3 | **160.3** | 586.6 |
| Income tax expense | **41.9** | 60.6 | **84.8** | 206.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $**68.7** | $141.7 | $**75.5** | $380.4 |
| Income per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $**0.12** | $0.33 | $**0.14** | $0.88 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**0.12** | $0.33 | $**0.14** | $0.88 |
| Weighted average common shares outstanding (Millions): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | **579.4** | 429.5 | **529.2** | 431.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | **583.1** | 430.9 | **533.9** | 432.6 |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>9</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

---

| | | |
|:---|:---|:---|
| | (Unaudited)<br>Nine Months Ended December 31 | (Unaudited)<br>Nine Months Ended December 31 |
| (Millions of US dollars) | **2025** | 2024 |
| **Cash Flows From Operating Activities** |  |  |
| Net income | $**75.5** | $380.4 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **330.5** | 156.8 |
| &nbsp;&nbsp;&nbsp;Lease expense | **30.6** | 24.6 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **5.6** | 94.8 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | **29.2** | 17.7 |
| &nbsp;&nbsp;&nbsp;Asbestos adjustments | **1.2** | 0.6 |
| &nbsp;&nbsp;&nbsp;Non-cash restructuring expenses | **1.1** | 40.2 |
| &nbsp;&nbsp;&nbsp;Non-cash interest expense | **6.9** | 1.5 |
| &nbsp;&nbsp;&nbsp;Non-cash charge related to step up of inventory | **47.9** |  |
| &nbsp;&nbsp;&nbsp;Gain on sale of land | **(26.2)** |  |
| &nbsp;&nbsp;&nbsp;Other, net | **33.4** | 17.0 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts and other receivables | **150.6** | 86.4 |
| &nbsp;&nbsp;&nbsp;Inventories | **(77.4)** | (20.5) |
| &nbsp;&nbsp;&nbsp;Operating lease assets and liabilities, net | **(34.4)** | (25.8) |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | **1.6** | (8.6) |
| &nbsp;&nbsp;&nbsp;Insurance receivable - Asbestos | **3.2** | 3.0 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | **(40.7)** | (15.6) |
| &nbsp;&nbsp;&nbsp;Claims and handling costs paid - Asbestos | **(86.8)** | (87.7) |
| &nbsp;&nbsp;&nbsp;Income taxes payable | **3.4** | (10.2) |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities and interest | **0.2** | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by operating activities** | $**455.4** | $657.4 |
| **Cash Flows From Investing Activities** |  |  |
| Purchases of property, plant and equipment | $**(302.8)** | $(333.0) |
| Proceeds from sale of property, plant and equipment | **108.2** |  |
| Capitalized interest | **(6.1)** | (16.7) |
| Cash consideration for The AZEK Company acquisition, net of cash acquired | **(3919.8)** |  |
| Purchase of restricted investments - Asbestos | **(141.7)** | (145.2) |
| Proceeds from restricted investments - Asbestos | **141.7** | 141.4 |
| Other | **—** | 0.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities** | $**(4120.5)** | $(353.1) |
| **Cash Flows From Financing Activities** |  |  |
| Proceeds from senior secured notes | $**1700.0** | $**—** |
| Proceeds from term loans | **2500.0** |  |
| Proceeds from revolving credit facility | **70.0** |  |
| Repayments of term loans | **(312.5)** | (5.6) |
| Repayment of senior unsecured notes | **(465.2)** |  |
| Debt issuance costs paid | **(41.6)** |  |
| Repayment of finance lease obligations | **(2.8)** | (0.9) |
| Shares repurchased | **—** | (149.9) |
| Taxes paid related to net share settlement of equity awards | **(11.7)** | (7.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) financing activities** | $**3436.2** | $(163.7) |
| Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos | $**(1.8)** | $1.1 |
| Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos | **(230.7)** | 141.7 |
| Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period | **605.6** | 415.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period** | $**374.9** | $557.5 |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>10</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

---

| | | |
|:---|:---|:---|
| | (Unaudited)<br>Nine Months Ended December 31 | (Unaudited)<br>Nine Months Ended December 31 |
| (Millions of US dollars) | **2025** | 2024 |
| **Non-Cash Investing and Financing Activities** |  |  |
| Capital expenditures incurred but not yet paid | $**23.3** | $23.2 |
| Non-cash ROU assets obtained in exchange for new lease liabilities | $**47.9** | $27.2 |
| Non-cash consideration for AZEK acquisition | $**4143.6** | $— |
| **Supplemental Disclosure of Cash Flow Activities** |  |  |
| Cash paid to AICF | $**62.7** | $49.6 |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>11</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

&nbsp;&nbsp;**Further Information**<br>

Readers are referred to the Company's Condensed Consolidated Financial Statements and Management's Analysis of Results for the third quarter ended December 31, 2025 for additional information regarding the Company's results.

All comparisons made are vs. the comparable period in the prior fiscal year and amounts presented are in US dollars, unless otherwise noted.

**Conference Call Details**<br>

James Hardie will hold a conference call to discuss results and outlook Tuesday, February 10, 2026 at 5:00pm EST (Wednesday, February 11, 2026 at 9:00am AEDT). Participants may register for a live webcast and access a replay following the event of the event on the Investor Relations section of the Company's website (ir.jameshardie.com).

**About James Hardie**<br>

James Hardie Industries plc is the industry leader in exterior home and outdoor living solutions, with a portfolio that includes fiber cement, fiber gypsum, and composite and PVC decking and railing products. Products offered by James Hardie are engineered for beauty, durability, and climate resilience, and include trusted brands like Hardie®, TimberTech®, AZEK® Exteriors, Versatex®, fermacell® and StruXure®. With a global footprint, the James Hardie portfolio is marketed and sold throughout North America, Europe, Australia and New Zealand.

James Hardie Industries plc is incorporated and existing under the laws of Ireland. As an Irish plc, James Hardie is governed by the Irish Companies Act. James Hardie's principal executive offices are located at 1st Floor, Block A, One Park Place, Upper Hatch Street, Dublin 2, D02 FD79, Ireland.

**Investor and Media Contact**<br>

investors@jameshardie.com

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>12</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Cautionary Note and Use of Non-GAAP Measures**

This Earnings Release includes financial measures that are not considered a measure of financial performance under generally accepted accounting principles in the United States (GAAP), such as Adjusted Net Income, Adjusted EBITDA, Adjusted Diluted EPS and Free Cash Flow. These non-GAAP financial measures should not be considered to be more meaningful than the equivalent GAAP measure. Management has included such measures to provide investors with an alternative method for assessing its operating results in a manner that is focused on the performance of its ongoing operations and excludes the impact of certain legacy items, such as asbestos adjustments, or significant non-recurring items, such as asset impairments, restructuring gain or expenses, acquisition and pre-close financing related costs, as well as adjustments to tax expense. Additionally, management uses such non-GAAP financial measures for the same purposes. However, these non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. A reconciliation of these adjustments to the most directly comparable GAAP measure is included in this Earnings Release below.

The Company is unable to forecast the comparable US GAAP financial measure for future periods due to, amongst other factors, uncertainty regarding the impact of actuarial estimates on asbestos-related assets and liabilities in future periods.

This Earnings Release contains forward-looking statements and information that are subject to risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements of James Hardie to be materially different from those expressed or implied in this release, including, among others, the risks and uncertainties set forth in Section 3 "Risk Factors" in James Hardie's Annual Report on Form 20-F for the fiscal year ended March 31, 2025; changes in general economic, political, governmental and business conditions globally and in the countries in which James Hardie does business; changes in interest rates; changes in inflation rates; changes in exchange rates; the level of construction generally; changes in cement demand and prices; changes in raw material and energy prices; changes in business strategy; the AZEK acquisition and various other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. James Hardie assumes no obligation to update or correct the information contained in this Earnings Release except as required by law.

This Earnings Release has been authorized by the James Hardie Board of Directors.

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>13</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**Non-GAAP Financial Measures**<br>

**<u>Adjusted EBITDA and Adjusted EBITDA margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Operating income** | $**176.2** | $**206.1** | $**338.8** | $**593.8** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.9 |
| Restructuring, net | (24.0) |  | (24.0) | 57.3 |
| Acquisition related expenses | 29.4 |  | 189.1 |  |
| Inventory fair value adjustment |  |  | 47.9 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  | 106.3 |  |
| Depreciation and amortization | 90.0 | 55.1 | 224.2 | 156.8 |
| **Adjusted EBITDA** | $**329.9** | $**262.1** | $**884.9** | $**810.8** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Operating income margin** | **14.2%** | **21.6%** | **9.9%** | **20.4%** |
| Asbestos related expenses and adjustments | 0.1% | 0.1% | 0.1% | 0.1% |
| Restructuring, net | (2.0)% | —% | (0.7%) | 2.0% |
| Acquisition related expenses | 2.4% | —% | 5.5% | —% |
| Inventory fair value adjustment | —% | —% | 1.4% | —% |
| Amortization of intangible assets resulting from AZEK acquisition | 4.6% | —% | 3.1% | —% |
| Depreciation and amortization | 7.3% | 5.8% | 6.5% | 5.4% |
| **Adjusted EBITDA margin** | **26.6%** | **27.5%** | **25.8%** | **27.9%** |

---

**Earnings Release: James Hardie - Third Quarter Ended December 31, 2025**<sub>14</sub>

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**<u>Adjusted net income and Adjusted diluted earnings per share</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions, except per share amounts** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Net income** | $**68.7** | $**141.7** | $**75.5** | $**380.4** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.9 |
| AICF interest income | (2.4) | (2.7) | (7.4) | (8.5) |
| Restructuring, net | (24.0) |  | (24.0) | 57.3 |
| Pre-close financing costs<sup>1</sup> |  |  | 46.5 |  |
| Acquisition related expenses | 29.4 |  | 189.1 |  |
| Inventory fair value adjustment |  |  | 47.9 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  | 106.3 |  |
| Tax adjustments<sup>2</sup> | 12.2 | 13.7 | (13.4) | 56.1 |
| **Adjusted net income** | $**142.2** | $**153.6** | $**423.1** | $**488.2** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Net income per common share - diluted** | $**0.12** | $**0.33** | $**0.14** | $**0.88** |
| Asbestos related expenses and adjustments |  |  |  | 0.01 |
| AICF interest income |  | (0.01) | (0.01) | (0.02) |
| Restructuring, net | (0.04) |  | (0.04) | 0.13 |
| Pre-close financing costs<sup>1</sup> |  |  | 0.09 |  |
| Acquisition related expenses | 0.05 |  | 0.35 |  |
| Inventory fair value adjustment |  |  | 0.09 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 0.09 |  | 0.20 |  |
| Tax adjustments<sup>2</sup> | 0.02 | 0.04 | (0.03) | 0.13 |
| **Adjusted diluted earnings per share**<sup>3</sup> | $**0.24** | $**0.36** | $**0.79** | $**1.13** |
| &nbsp;&nbsp;<sup>1.</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2.</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br><sup>3.</sup>Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. | &nbsp;&nbsp;<sup>1.</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2.</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br><sup>3.</sup>Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. | &nbsp;&nbsp;<sup>1.</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2.</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br><sup>3.</sup>Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. | &nbsp;&nbsp;<sup>1.</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2.</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br><sup>3.</sup>Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. | &nbsp;&nbsp;<sup>1.</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2.</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br><sup>3.</sup>Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. |

---

---

| | |
|:---|:---|
| **Earnings Release: James Hardie - Third Quarter Ended December 31, 2025** | **15** |

---

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**<u>Siding & Trim</u> <u>Segment Adjusted EBITDA and Adjusted EBITDA margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Siding & Trim Segment operating income** | $**202.9** | $**209.3** | $**515.1** | $**638.5** |
| Acquisition related expenses | 3.6 |  | 8.4 |  |
| Inventory fair value adjustment |  |  | 11.2 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 12.8 |  | 23.6 |  |
| Depreciation and amortization | 49.3 | 41.2 | 140.1 | 115.5 |
| **Siding & Trim Segment Adjusted EBITDA** | $**268.6** | $**250.5** | $**698.4** | $**754.0** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Siding & Trim Segment operating income margin** | **25.7%** | **29.1%** | **23.5%** | **29.8%** |
| Acquisition related expenses | 0.5% | —% | 0.4% | —% |
| Inventory fair value adjustment | —% | —% | 0.5% | —% |
| Amortization of intangible assets resulting from AZEK acquisition | 1.6% | —% | 1.0% | —% |
| Depreciation and amortization | 6.3% | 5.7% | 6.4% | 5.4% |
| **Siding & Trim Segment Adjusted EBITDA margin** | **34.1%** | **34.8%** | **31.8%** | **35.2%** |

---

**<u>Deck, Rail & Accessories Segment Adjusted EBITDA and Adjusted EBITDA margin</u>**

---

| | | |
|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **FY26** |
| **Deck, Rail & Accessories Segment operating loss** | $**(24.0)** | $**(35.9)** |
| Restructuring expenses | 2.2 | 2.2 |
| Inventory fair value adjustment |  | 36.7 |
| Amortization of intangible assets resulting from AZEK acquisition | 44.8 | 82.7 |
| Depreciation and amortization | 25.7 | 41.6 |
| **Deck, Rail & Accessories Segment Adjusted EBITDA** | $**48.7** | $**127.3** |

---

---

| | | |
|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **FY26** |
| **Deck, Rail & Accessories Segment operating loss margin** | **(12.4** **%)** | **(8.0** **%)** |
| Restructuring expenses | 1.1% | 0.5% |
| Inventory fair value adjustment | —% | 8.1% |
| Amortization of intangible assets resulting from AZEK acquisition | 23.1% | 18.4% |
| Depreciation and amortization | 13.3% | 9.3% |
| **Deck, Rail & Accessories Segment Adjusted EBITDA margin** | **25.1%** | **28.3%** |

---

---

| | |
|:---|:---|
| **Earnings Release: James Hardie - Third Quarter Ended December 31, 2025** | **16** |

---

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**<u>Australia & New Zealand Segment Adjusted EBITDA and Adjusted EBITDA margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Australia & New Zealand Segment operating income** | $**35.6** | $**34.8** | $**111.4** | $**68.0** |
| Restructuring expenses |  |  |  | 57.3 |
| Depreciation and amortization | 5.6 | 4.9 | 16.3 | 14.4 |
| **Australia & New Zealand Segment Adjusted EBITDA** | $**41.2** | $**39.7** | $**127.7** | $**139.7** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Australia & New Zealand Segment operating income margin** | **28.1%** | **29.3%** | **29.2%** | **17.2%** |
| Restructuring expenses | —% | —% | —% | 13.9% |
| Depreciation and amortization | 4.5% | 4.2% | 4.3% | 3.6% |
| **Australia & New Zealand Segment Adjusted EBITDA margin** | **32.6%** | **33.5%** | **33.5%** | **34.7%** |

---

**<u>Europe Segment EBITDA and EBITDA margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Europe Segment operating income** | $**9.1** | $**3.6** | $**37.9** | $**24.7** |
| Depreciation and amortization | 7.5 | 8.3 | 21.6 | 23.9 |
| **Europe Segment EBITDA** | $**16.6** | $**11.9** | $**59.5** | $**48.6** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Europe Segment operating income margin** | **7.0%** | **3.1%** | **9.4%** | **6.8%** |
| Depreciation and amortization | 5.7% | 7.2% | 5.3% | 6.7% |
| **Europe Segment EBITDA margin** | **12.7%** | **10.3%** | **14.7%** | **13.5%** |

---

**<u>Adjusted General Corporate and Unallocated R&D EBITDA</u>**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** |  | **FY26** | **FY25** |
| **General Corporate and Unallocated R&D costs** | $**(47.4)** | $**(41.6)** | $**289.7** | $**(289.7)** | $**(137.4)** |
| Restructuring gain | (26.2) |  | (26.2) | (26.2) |  |
| Acquisition related expenses | 25.8 |  | 180.7 | 180.7 |  |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.6 | 2.9 |
| Depreciation and amortization | 1.9 | 0.7 |  | 4.6 | 3.0 |
| **Adjusted General Corporate and Unallocated R&D EBITDA** | $**(45.2)** | $**(40.0)** |  | $**(128.0)** | $**(131.5)** |

---

---

| | |
|:---|:---|
| **Earnings Release: James Hardie - Third Quarter Ended December 31, 2025** | **17** |

---

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**<u>Adjusted income before income taxes, Adjusted income tax expense and Adjusted effective tax rate</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Income before income taxes** | $**110.6** | $**202.3** | $**160.3** | $**586.6** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.9 |
| AICF interest income | (2.4) | (2.7) | (7.4) | (8.5) |
| Restructuring, net | (24.0) |  | (24.0) | 57.3 |
| Pre-close financing costs<sup>1</sup> |  |  | 46.5 |  |
| Acquisition related expenses | 29.4 |  | 189.1 |  |
| Inventory fair value adjustment |  |  | 47.9 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  | 106.3 |  |
| **Adjusted income before income taxes** | $**171.9** | $**200.5** | $**521.3** | $**638.3** |
| **Income tax expense** | $**41.9** | $**60.6** | $**84.8** | $**206.2** |
| Tax adjustments<sup>2</sup> | (12.2) | (13.7) | 13.4 | (56.1) |
| **Adjusted income tax expense** | $**29.7** | $**46.9** | $**98.2** | $**150.1** |
| Effective tax rate | 37.9% | 30.0% | 52.9% | 35.2% |
| **Adjusted effective tax rate** | **17.3%** | **23.4%** | **18.8%** | **23.5%** |
| &nbsp;&nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of $34.9 million as well as a $11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. |

---

**<u>Adjusted interest, net</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Interest, net** | $**65.6** | $**3.8** | $**168.8** | $**7.4** |
| Pre-close financing and interest costs |  |  | (34.9) |  |
| AICF interest income | 2.4 | 2.7 | 7.4 | 8.5 |
| **Adjusted interest, net** | $**68.0** | $**6.5** | $**141.3** | $**15.9** |

---

**<u>Adjusted other income, net</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 | Three and Nine Months Ended December 31 |
|  | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Other expense (income), net** | $**—** | $**—** | $**9.7** | $**(0.2)** |
| Non-cash loss on interest rate swap |  |  | (11.6) |  |
| **Adjusted other income, net** | $**—** | $**—** | $**(1.9)** | $**(0.2)** |

---

---

| | |
|:---|:---|
| **Earnings Release: James Hardie - Third Quarter Ended December 31, 2025** | **18** |

---

------

---

| | |
|:---|:---|
| **Earnings Release**<br>**February 10, 2026** | ![logoa.jpg](logoa.jpg) |

---

**<u>Net Debt</u>**

---

| | |
|:---|:---|
| **US$ Millions** | **December 31** |
| | **FY26** |
| Total principal amount of debt | $4648.1 |
| Cash and cash equivalents | (344.2) |
| **Net debt** | $**4303.9** |

---

**<u>Free Cash Flow</u>**

---

| | | |
|:---|:---|:---|
| **US$ Millions** | **Nine Months Ended December 31** | **Nine Months Ended December 31** |
| | **FY26** | **FY25** |
| **Net cash provided by operating activities** | $**455.4** | $**657.4** |
| Purchases of property, plant and equipment | (302.8) | (333.0) |
| Proceeds from sale of property, plant and equipment | 108.2 |  |
| **Free Cash Flow** | $**260.8** | $**324.4** |

---

---

| | |
|:---|:---|
| **Earnings Release: James Hardie - Third Quarter Ended December 31, 2025** | **19** |

---

## Exhibit 99.3

---

| | |
|:---|:---|
| **Fiscal Year 2026<br>Three and Nine Months Ended <br>31 December 2025** | ![jhlogo1.jpg](jhlogo1.jpg) |

---

 **Exhibit 99.3**

**Management's Analysis of Results**

This Management's Analysis of Results forms part of a package of information about James Hardie Industries plc's results. It should be read in conjunction with the other parts of this package, including the Earnings Release, the Earnings Presentation and the Condensed Consolidated Financial Statements. Except as otherwise indicated in this Management's Analysis of Results, James Hardie Industries plc is referred to as "JHI plc." JHI plc, together with its direct and indirect wholly-owned subsidiaries, are collectively referred to as "James Hardie", the "Company", "we", "our", or "us". Definitions for certain capitalized terms used in this Management's Analysis of Results can be found in the section titled "Non-GAAP Financial Measures".

This Management's Analysis of Results includes financial measures that are not considered a measure of financial performance under generally accepted accounting principles in the United States ("GAAP"). These non-GAAP financial measures should not be considered to be more meaningful than the equivalent GAAP measures. Management has included such measures to provide investors with an alternative method for assessing the Company's financial condition and operating results in a manner that is focused on the performance of its ongoing operations. These measures exclude the impact of certain legacy items, such as asbestos adjustments, or significant non-recurring items, such as asset impairments, restructuring gain or expenses, acquisition and pre-close financing related costs, as well as adjustments to tax expense. In addition, management provides an adjusted effective tax rate, which excludes the tax impact of the special pre-tax items (items listed above) and special tax items. Management believes that this non-GAAP tax measure provides an ongoing effective rate which investors may find useful for historical comparisons and for forecasting and is an alternative method of assessing the economic impact of taxes on the Company, as it more closely approximates payments to taxing authorities. Management uses such non-GAAP financial measures for the same purposes. These non-GAAP measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. These non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. For additional information regarding the non-GAAP financial measures presented in this Management's Analysis of Results, including a reconciliation of each non-GAAP financial measure to the equivalent GAAP measure, see the section titled "Non-GAAP Financial Measures".

These documents, along with an audio webcast of the Earnings Presentation are available from the Investor Relations area of our website at <u>https://ir.jameshardie.com.au/financial-information/financial-results</u>.

**Investor and Media Contact**

---

| | |
|:---|:---|
| **Email:** &nbsp;&nbsp;&nbsp;&nbsp; | investors@jameshardie.com |

---

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>1</sub>

------

---

| | |
|:---|:---|
| CONSOLIDATED RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Overview**

James Hardie Industries plc is a leading provider of exterior home and outdoor living solutions. On 1 July 2025, we completed the acquisition of The AZEK Company Inc. ("AZEK"), an industry-leading designer and manufacturer of low maintenance and environmentally sustainable outdoor living products, which has manufacturing and recycling facilities in the United States. The results below are based on preliminary purchase price calculations and allocations, and these estimates and assumptions are subject to change as additional information is obtained during the measurement period, which may be up to one year from the acquisition date.

**Results of Operations**

<u>Q3 FY26 vs Q3 FY25</u>

---

| | | | |
|:---|:---|:---|:---|
| **US$ Millions** | **Three Months Ended 31 December** | **Three Months Ended 31 December** | **Three Months Ended 31 December** |
| | **FY26** | **FY25** | **Change** |
| Net sales | $1239.8 | $953.3 | 30% |
| Cost of goods sold | 791.6 | 590.9 | 34% |
| Gross profit | 448.2 | 362.4 | 24% |
| &nbsp;&nbsp;*Gross margin (%)* | *36.2* | *38.0* | *(1.8 pts)* |
| Selling, general and administrative expenses | 249.7 | 144.7 | 73% |
| Research and development expenses | 16.6 | 11.5 | 44% |
| Restructuring, net | (24.0) |  | (100%) |
| Acquisition related expenses | 29.4 |  | 100% |
| Asbestos adjustments | 0.3 | 0.1 | 200% |
| Operating income | 176.2 | 206.1 | (15%) |
| &nbsp;&nbsp;*Operating income margin (%)* | *14.2* | *21.6* | *(7.4 pts)* |
| Interest, net | 65.6 | 3.8 | NM |
| Income tax expense | 41.9 | 60.6 | (31%) |
| Net income | 68.7 | 141.7 | (52%) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Net sales** increased 30% primarily due to the AZEK acquisition, which accounted for US$275.0 million of the increase, along with higher net sales in the Europe and Australia & New Zealand segments. This was partially offset by lower net sales in our North America fiber cement business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Gross margin** decreased 1.8 percentage points primarily due to the amortization of certain intangible assets resulting from the AZEK acquisition of US$12.2 million and lower gross margin in our North America fiber cement business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Restructuring, net** includes a US$26.2 million gain on the sale of land as a result of our strategic decision to cancel the Truganina greenfield project as mentioned in fiscal year 2024. Included in FY24 was a US$20.1 million impairment on this property, based on the information available at that time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Operating income margin** decreased 7.4 percentage points, driven by AZEK acquisition related expenses of US$29.4 million, lower gross margin and higher SG&A expenses as a percentage of sales largely driven by the amortization of certain intangible assets resulting from the AZEK acquisition recorded in SG&A of US$45.4 million. This decrease was partially offset by the gain on sale of land as mentioned above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Interest, net** increased US$61.8 million driven by a higher principal balance outstanding related to our US$2.5 billion senior secured credit facilities (the "Credit Facilities") and US$1.7 billion senior secured notes (the "Notes").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Net income** decreased US$73.0 million due to lower operating income and higher interest expense attributable to the factors described above, partially offset by lower income tax expense.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>2</sub>

------

---

| | |
|:---|:---|
| CONSOLIDATED RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

<u>Nine Months FY26 vs Nine Months FY25</u>

---

| | | | |
|:---|:---|:---|:---|
| **US$ Millions** | **Nine Months Ended 31 December** | **Nine Months Ended 31 December** | **Nine Months Ended 31 December** |
| | **FY26** | **FY25** | **Change** |
| Net sales | $3431.9 | $2906.0 | 18% |
| Cost of goods sold | 2225.7 | 1773.8 | 25% |
| Gross profit | 1206.2 | 1132.2 | 7% |
| &nbsp;&nbsp;*Gross margin (%)* | *35.1* | *39.0* | *(3.9 pts)* |
| Selling, general and administrative expenses | 656.6 | 444.4 | 48% |
| Research and development expenses | 44.5 | 36.1 | 23% |
| Restructuring, net | (24.0) | 57.3 | (142%) |
| Acquisition related expenses | 189.1 |  | 100% |
| Asbestos adjustments | 1.2 | 0.6 | 100% |
| Operating income | 338.8 | 593.8 | (43%) |
| &nbsp;&nbsp;*Operating income margin (%)* | *9.9* | *20.4* | *(10.5 pts)* |
| Interest, net | 168.8 | 7.4 | NM |
| Other expense (income), net | 9.7 | (0.2) | NM |
| Income tax expense | 84.8 | 206.2 | (59%) |
| Net income | 75.5 | 380.4 | (80%) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Net sales** increased 18% primarily due to the AZEK acquisition, which contributed net sales of US$620.1 million, as well as higher net sales in Europe. This was partially offset by lower net sales in our legacy North America fiber cement business and Australia & New Zealand segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Gross margin** decreased 3.9 percentage points mainly driven by a US$47.9 million inventory step-up adjustment related to recording the acquired inventory of AZEK at fair value, which was fully recognized during the year, and amortization of certain intangible assets resulting from the AZEK acquisition of US$24.6 million, as well as lower gross margin in the North America fiber cement business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Operating income margin** decreased 10.5 percentage points to 9.9%, driven by AZEK acquisition related expenses of US$189.1 million, lower gross margin and higher SG&A expenses as a percentage of sales largely driven by the amortization of certain intangible assets resulting from the AZEK acquisition recorded in SG&A of US$81.7 million. This decrease was partially offset by the US$26.2 million gain related to the land sale discussed above and restructuring expenses of US$57.3 million in the prior year related to the closure of our Philippines manufacturing and commercial operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Interest, net** increased US$161.4 million driven by a higher principal balance outstanding related to our new Credit Facilities and Notes, and pre-close financing and interest costs of US$34.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Net income** decreased US$304.9 million due to lower operating income and higher interest expense attributable to the factors described above, as well as an US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026. This was partially offset by lower income tax expense.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>3</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Segment Results of Operations**

As a result of completing the AZEK acquisition on 1 July 2025, beginning with the second quarter of FY26, we report our results in four reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Siding & Trim** - consisting of the legacy North America Fiber Cement segment and the acquired Exteriors business from AZEK.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Deck, Rail & Accessories** - consisting of AZEK's Deck, Rail & Accessories business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Australia & New Zealand** - consisting of the legacy Asia Pacific Fiber Cement segment. This segment includes fiber cement products manufactured in Australia and sold in Australia and New Zealand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Europe** - consisting of the legacy Europe Building Products segment. The Europe segment includes fiber gypsum products and cement bonded boards manufactured in Europe, and fiber cement products manufactured in the United States that are sold in Europe.

**Siding & Trim Segment**

Operating results for the Siding & Trim segment were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **Change** | **FY26** | **FY25** | **Change** |
| Net sales | $788.3 | $719.3 | 10% | $2196.1 | $2144.4 | 2% |
| Cost of goods sold | 481.2 | 435.5 | 10% | 1382.2 | 1281.2 | 8% |
| Gross profit | 307.1 | 283.8 | 8% | 813.9 | 863.2 | (6%) |
| &nbsp;&nbsp;*Gross margin (%)* | *39.0* | *39.5* | *(0.5 pts)* | *37.1* | *40.3* | *(3.2 pts)* |
| Selling, general and administrative expenses | 89.3 | 72.7 | 23% | 265.9 | 217.6 | 22% |
| Research and development expenses | 11.3 | 1.8 | 528% | 24.5 | 7.1 | 245% |
| Acquisition related expenses | 3.6 |  | 100% | 8.4 |  | 100% |
| Operating income | 202.9 | 209.3 | (3%) | 515.1 | 638.5 | (19%) |
| &nbsp;&nbsp;*Operating income margin (%)* | *25.7* | *29.1* | *(3.4 pts)* | *23.5* | *29.8* | *(6.3 pts)* |
| Adjusted operating income<sup>1</sup> | 219.3 | 209.3 | 5% | 558.3 | 638.5 | (13%) |
| &nbsp;&nbsp;*Adjusted operating income margin (%)*<sup>1</sup> | *27.8* | *29.1* | *(1.3 pts)* | *25.4* | *29.8* | *(4.4 pts)* |
| <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure |  |

---

<u>Q3 FY26 vs Q3 FY25</u>

Net sales increased 10% driven by sales of US$80.9 million associated with the acquired AZEK Exteriors business, which were in line with AZEK's net sales for the quarter ended 31 December 2024 prior to the acquisition. Net sales in our North America fiber cement business decreased 2% primarily due to market weakness, partially offset by a higher average net sales price primarily resulting from our annual price increase.

Gross margin decreased 0.5 percentage points driven by our North America fiber cement business which had unfavorable production cost absorption and higher freight and raw material costs, partially offset by a higher average net sales price and US$4.7 million of startup costs at our Prattville facility in the prior corresponding period. In addition, gross margin was unfavorably impacted by the amortization of certain intangible assets resulting from the AZEK acquisition of US$1.2 million.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>4</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

SG&A expenses increased 23%, and as a percentage of sales, SG&A increased 1.2 percentage points. This increase was driven by AZEK, including the amortization of certain intangible assets resulting from the AZEK acquisition of US$11.6 million, and employee and marketing costs. This was partly offset by lower SG&A expenses in our North America fiber cement business mainly due to lower marketing expenses.

R&D expenses increased US$9.5 million primarily due to the allocation of certain R&D expenses which were not allocated to our segments prior to the second quarter of fiscal year 2026.

Operating income margin decreased 3.4 percentage points to 25.7%, primarily driven by lower gross margin and higher SG&A and R&D expenses.

<u>Nine Months FY26 vs Nine Months FY25</u>

Net sales increased 2% driven by sales of US$170.2 million associated with the newly acquired AZEK business. North America fiber cement sales declined 6% primarily due to market weakness, partially offset by a higher average net sales price primarily resulting from our annual price increase.

Gross margin decreased 3.2 percentage points driven by our North America fiber cement business primarily due to unfavorable production cost absorption and higher pulp and other raw material costs. This was partially offset by a higher average net sales price and US$12.1 million of startup costs at our Prattville and Westfield facilities in the prior corresponding period. In addition, gross margin was unfavorably impacted by the inventory step-up adjustment of US$11.2 million which was fully recognized during the year, as well as the amortization of certain intangible assets resulting from the AZEK acquisition of US$2.8 million.

SG&A expenses increased 22%, and as a percentage of sales, SG&A expenses increased 2.0 percentage points. This increase was primarily driven by AZEK, including the amortization of certain intangible assets resulting from the AZEK acquisition of US$20.8 million, and higher employee and marketing costs.

R&D expenses increased US$17.4 million primarily due to the allocation of certain R&D expenses which were not allocated to our segments prior to the second quarter of fiscal year 2026.

Operating income margin decreased 6.3 percentage points to 23.5%, primarily driven by lower gross margin and higher SG&A and R&D expenses.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>5</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

b

**Deck, Rail & Accessories Segment**

Operating results for the Deck, Rail & Accessories segment were as follows:

---

| | | |
|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **FY26** |
| Net sales | $194.1 | $449.9 |
| Cost of goods sold | 143.8 | 343.8 |
| Gross profit | 50.3 | 106.1 |
| &nbsp;&nbsp;*Gross margin (%)* | *25.9* | *23.6* |
| Selling, general and administrative expenses | 69.7 | 134.9 |
| Research and development expenses | 2.4 | 4.9 |
| Restructuring expenses | 2.2 | 2.2 |
| Operating loss | (24.0) | (35.9) |
| &nbsp;&nbsp;*Operating loss margin (%)* | *(12.4)* | *(8.0)* |
| Adjusted operating income<sup>1</sup> | 23.0 | 85.7 |
| &nbsp;&nbsp;*Adjusted operating income margin (%)*<sup>1</sup> | *11.8* | *19.0* |
| <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure |  |

---

<u>Q3 FY26</u>

Net sales of US$194.1 million were 2% higher than AZEK's net sales for the quarter ended 31 December 2024 prior to the acquisition.

Gross margin of 25.9% includes the amortization of certain intangible assets resulting from the AZEK acquisition of US$11.0 million.

SG&A expenses of US$69.7 million include the amortization of certain intangible assets resulting from the AZEK acquisition of US$33.8 million, which includes the impact of revisions to the fair value of intangible assets acquired, which is subject to change as additional information is obtained during the measurement period, which may be up to one year from the acquisition date.

Restructuring expenses of US$2.2 million includes exit costs related to the closure of a recycling plant in Oregon.

Operating loss of US$24.0 million includes the amortization of certain intangible assets resulting from the AZEK acquisition of US$44.8 million.

<u>Nine Months FY26</u>

Net sales of US$449.9 million were 4% higher than AZEK's net sales for the comparable period in 2024 prior to the acquisition.

Gross margin of 23.6% includes a US$36.7 million inventory step-up adjustment related to recording the acquired inventory of AZEK at fair value, which was fully recognized during the year, as well as the amortization of certain intangible assets resulting from the AZEK acquisition of US$21.8 million.

SG&A expenses of US$134.9 million includes the amortization of certain intangible assets resulting from the AZEK acquisition of US$60.9 million.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>6</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

The operating loss of US$35.9 million includes a US$36.7 million inventory step-up adjustment related to recording the acquired inventory of AZEK at fair value, which was fully recognized during the year, as well as the amortization of certain intangible assets resulting from the AZEK acquisition of US$82.7 million.

**Australia & New Zealand Segment**

Operating results for the Australia & New Zealand segment in US dollars were as follows. In fiscal year 2025, this segment also included the Philippines which ceased manufacturing operations in August 2024, with commercial operations largely wound down by the end of September 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **Change** | **FY26** | **FY25** | **Change** |
| Net sales | $126.5 | $118.1 | 7% | $381 | $401.8 | (5%) |
| Cost of goods sold | 75.0 | 68.9 | 9% | 220.6 | 233.4 | (5%) |
| Gross profit | 51.5 | 49.2 | 5% | 160.4 | 168.4 | (5%) |
| &nbsp;&nbsp;*Gross margin (%)* | *40.7* | *41.6* | *(0.9 pts)* | *42.1* | *41.9* | *0.2 pts* |
| Selling, general and administrative expenses | 14.3 | 14.0 | 2% | 45.6 | 42.1 | 8% |
| Restructuring expenses |  |  | —% |  | 57.3 | (100%) |
| Research and development expenses | 1.6 | 0.4 | 300% | 3.4 | 1.0 | 240% |
| Operating income | 35.6 | 34.8 | 2% | 111.4 | 68.0 | 64% |
| &nbsp;&nbsp;*Operating income margin (%)* | *28.1* | *29.3* | *(1.2 pts)* | *29.2* | *17.2* | *12.0 pts* |
| Adjusted operating income<sup>1</sup> | 35.6 | 34.8 | 2% | 111.4 | 125.3 | (11%) |
| &nbsp;&nbsp;*Adjusted operating income margin (%)*<sup>1</sup> | *28.1* | *29.3* | *(1.2 pts)* | *29.2* | *31.1* | *(1.9 pts)* |
| <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure |  |  |

---

Operating results for the Australia & New Zealand segment in Australian dollars were as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **A$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY26** | **Q3 FY25** | **Q3 FY25** | **Change** | **FY26** | **FY26** | **FY25** | **Change** |
| Net sales | A$ | 192.9 | A$ | 180.1 | 7% | A$ | 585.6 | 606.9 | (4%) |
| Cost of goods sold | 114.3 | 114.3 | 105.2 | 105.2 | 9% | 339.0 | 339.0 | 352.7 | (4%) |
| Gross profit | 78.6 | 78.6 | 74.9 | 74.9 | 5% | 246.6 | 246.6 | 254.2 | (3%) |
| &nbsp;&nbsp;*Gross margin (%)* | *40.7* | *40.7* | *41.6* | *41.6* | *(0.9 pts)* | *42.1* | *42.1* | *41.9* | *0.2 pts* |
| Selling, general and administrative expenses | 21.8 | 21.8 | 21.5 | 21.5 | 1% | 70.1 | 70.1 | 63.7 | 10% |
| Restructuring expenses |  |  |  |  | —% |  |  | 84.7 | (100%) |
| Research and development expenses | 2.5 | 2.5 | 0.6 | 0.6 | 317% | 5.2 | 5.2 | 1.5 | 247% |
| Operating income | 54.3 | 54.3 | 52.8 | 52.8 | 3% | 171.3 | 171.3 | 104.3 | 64% |
| &nbsp;&nbsp;*Operating income margin (%)* | *28.1* | *28.1* | *29.3* | *29.3* | *(1.2 pts)* | *29.2* | *29.2* | *17.2* | *12.0 pts* |
| Adjusted operating income<sup>1</sup> | 54.3 | 54.3 | 52.8 | 52.8 | 3% | 171.3 | 171.3 | 189.0 | (9%) |
| &nbsp;&nbsp;*Adjusted operating income margin (%)*<sup>1</sup> | *28.1* | *28.1* | *29.3* | *29.3* | *(1.2 pts)* | *29.2* | *29.2* | *31.1* | *(1.9 pts)* |
| <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure | <sup>1</sup> See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure |  |  |

---

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>7</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

<u>Q3 FY26 vs Q3 FY25(A$)</u>

Net sales increased 7%, primarily driven by a higher average net sales price attributable to our price increase and favorable product mix, and volume growth in Australia and New Zealand.

Gross margin decreased 0.9 percentage points primarily due to unfavorable production cost absorption, partially offset by a higher average net sales price.

SG&A expenses increased 1% primarily due to higher employee costs, partially offset by the closure of our Philippines operations. As a percentage of sales, SG&A expenses decreased 0.6 percentage points.

R&D expenses increased A$1.9 million primarily due to the allocation of certain R&D expenses which were previously unallocated to our segments prior to the second quarter of fiscal year 2026.

Lower operating income margin resulted primarily from lower gross margin and higher R&D expenses.

<u>Nine Months FY26 vs Nine Months FY25 (A$)</u>

Net sales decreased 4%, driven by lower volumes of 16%, partially offset by a higher average net sales price. The decline in volumes and higher price were primarily attributable to the closure of our Philippines manufacturing and commercial operations. Net sales from the Philippines for the nine months ended December 2024 was A$39.2 million.

Gross margin increased 0.2 percentage points primarily due to a higher average net sales price and geographic mix, partially offset by unfavorable plant performance.

SG&A expenses increased 10% primarily due to recording a lease exit cost, as well as higher marketing and employee costs, partially offset by the closure of our Philippines operations. As a percentage of sales, SG&A expenses increased 1.5 percentage points.

R&D expenses increased A$3.7 million primarily due to the allocation of certain R&D expenses which were previously unallocated to our segments prior to the second quarter of fiscal year 2026.

Higher operating income margin resulted primarily from the absence of restructuring expenses in the current year and higher gross margin, partially offset by higher SG&A and R&D expenses. Prior year included restructuring expenses of A$84.7 million related to the closure of our Philippines manufacturing and commercial operations.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>8</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Europe Segment**

Operating results for the Europe segment in US dollars were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **Change** | **FY26** | **FY25** | **Change** |
| Net sales | $130.9 | $115.9 | 13% | $404.9 | $359.8 | 13% |
| Cost of goods sold | 91.6 | 86.5 | 6% | 279.1 | 259.2 | 8% |
| Gross profit | 39.3 | 29.4 | 34% | 125.8 | 100.6 | 25% |
| &nbsp;&nbsp;*Gross margin (%)* | *30.0* | *25.4* | *4.6 pts* | *31.1* | *27.9* | *3.2 pts* |
| Selling, general and administrative expenses | 29.1 | 25.1 | 16% | 85.1 | 74.1 | 15% |
| Research and development expenses | 1.1 | 0.7 | 57% | 2.8 | 1.8 | 56% |
| Operating income | 9.1 | 3.6 | 153% | 37.9 | 24.7 | 53% |
| &nbsp;&nbsp;*Operating income margin (%)* | *7.0* | *3.1* | *3.9 pts* | *9.4* | *6.8* | *2.6 pts* |

---

Operating results for the Europe segment in Euros were as follows:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **€ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY26** | **Q3 FY25** | **Q3 FY25** | **Change** | **FY26** | **FY26** | **FY25** | **FY25** | **Change** |
| Net sales | € | 112.4 | € | 108.6 | 3% | € | 350.4 | € | 332.9 | 5% |
| Cost of goods sold | 78.7 | 78.7 | 81.0 | 81.0 | (3%) | 241.5 | 241.5 | 239.9 | 239.9 | 1% |
| Gross profit | 33.7 | 33.7 | 27.6 | 27.6 | 22% | 108.9 | 108.9 | 93.0 | 93.0 | 17% |
| &nbsp;&nbsp;*Gross margin (%)* | *30.0* | *30.0* | *25.4* | *25.4* | *4.6 pts* | *31.1* | *31.1* | *27.9* | *27.9* | *3.2 pts* |
| Selling, general and administrative expenses | 24.9 | 24.9 | 23.6 | 23.6 | 6% | 73.6 | 73.6 | 68.5 | 68.5 | 7% |
| Research and development expenses | 0.9 | 0.9 | 0.6 | 0.6 | 50% | 2.4 | 2.4 | 1.7 | 1.7 | 41% |
| Operating income | 7.9 | 7.9 | 3.4 | 3.4 | 132% | 32.9 | 32.9 | 22.8 | 22.8 | 44% |
| &nbsp;&nbsp;*Operating income margin (%)* | *7.0* | *7.0* | *3.1* | *3.1* | *3.9 pts* | *9.4* | *9.4* | *6.8* | *6.8* | *2.6 pts* |

---

<u>Q3 FY26 vs Q3 FY25 (€)</u>

Net sales increased 3% driven by higher fiber gypsum volume, partially offset by lower fiber cement volume. Average net sales price was down 2% due to product mix.

Gross margin increased 4.6 percentage points primarily due to lower paper and gypsum costs and favorable plant performance, partially offset by higher energy and freight costs.

SG&A expenses increased 6% due to higher labor costs and marketing spend. As a percentage of sales, SG&A expenses increased 0.5 percentage points.

Operating income margin of 7.0% increased 3.9 percentage points primarily driven by higher gross margin, partially offset by higher SG&A expenses.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>9</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

<u>Nine Months FY26 vs Nine Months FY25 (€)</u>

Net sales increased 5% primarily due a 5% increase in volume, driven by higher fiber gypsum volume and higher price resulting from our June 2024 and January 2025 price increases partially offset by product mix.

Gross margin increased 3.2 percentage points primarily due to lower freight and paper costs as well as favorable plant performance, partially offset by higher energy costs.

SG&A expenses increased 7% driven by higher labor costs and marketing spend. As a percentage of sales, SG&A expenses increased 0.4 percentage points.

Operating income margin of 9.4% increased 2.6 percentage points primarily driven by higher gross margin, partially offset by higher SG&A expenses.

**General Corporate and Unallocated R&D costs**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **Change %** | **FY26** | **FY25** | **Change %** |
| General Corporate and Unallocated R&D costs | $47.4 | $41.6 | 14 | $289.7 | $137.4 | 111 |
| Excluding: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition related expenses | (25.8) |  | 100 | (180.7) |  | 100 |
| &nbsp;&nbsp;&nbsp;Restructuring gain | 26.2 |  | 100 | 26.2 |  | 100 |
| &nbsp;&nbsp;&nbsp;Asbestos related expenses and adjustments | (0.7) | (0.9) | (22) | (2.6) | (2.9) | (10) |
| Adjusted General Corporate and Unallocated R&D costs | $**47.1** | $**40.7** | **16** | $**132.6** | $**134.5** | **(1)** |

---

General Corporate and Unallocated R&D costs for the three and nine month periods of US$47.4 million and US$289.7 million, respectively, includes acquisition related expenses of US$25.8 million and US$180.7 million, respectively. These costs primarily relate to professional service fees, severance and retention costs and the acceleration of certain stock awards associated with the AZEK acquisition. This was partially offset by a US$26.2 million gain on the sale of land in Q3 FY26 as a result of our strategic decision to cancel the Truganina greenfield project, as mentioned in fiscal year 2024.

For the three month period, Adjusted General Corporate and Unallocated R&D costs increased US$6.4 million mainly due to AZEK expenses related to stock compensation, employee costs and professional fees, as well as higher legacy Corporate costs which were driven by higher stock compensation expense, employee costs and professional fees. These costs were partially offset by the allocation of previously unallocated R&D costs to our segments beginning 1 July 2025.

For the nine month period, Adjusted General Corporate and Unallocated R&D costs decreased US$1.9 million mainly due to the allocation of R&D costs noted above. In addition, lower legacy Corporate costs, driven mainly by lower employee and legal costs, were more than offset by AZEK expenses related to stock compensation, employee costs and professional fees.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>10</sub>

------

---

| | |
|:---|:---|
| OPERATING RESULTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Income Tax**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
|  | **Q3 FY26** | **Q3 FY25** | **Change** | **FY26** | **FY25** | **Change** |
| Income tax expense | $41.9 | $60.6 | (31%) | $84.8 | $206.2 | (59%) |
| Effective tax rate (%) | 37.9 | 30.0 | 7.9 pts | 52.9 | 35.2 | 17.7 pts |
| Adjusted income tax expense<sup>1</sup>  | $29.7 | $46.9 | (37%) | $98.2 | $150.1 | (35%) |
| Adjusted effective tax rate<sup>1</sup> (%) | 17.3 | 23.4 | (6.1 pts) | 18.8 | 23.5 | (4.7 pts) |
| &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. See section titled "Non-GAAP Financial Measures" for a reconciliation to the equivalent GAAP measure. |

---

The effective tax rate increased 7.9 percentage points and 17.7 percentage points for the three and nine month periods, respectively, due to the reduction in net income compared to the previous corresponding periods. The discrete items related to the ATO settlement agreement and AZEK acquisition costs recognized in Q2 FY26 also drove the increase in the nine month effective tax rate.

The adjusted effective tax rate decreased 6.1 percentage points and 4.7 percentage points for the three and nine month periods, respectively, primarily due to a change in geographical mix of taxable earnings, including the effects of the increase in debt in our US subsidiaries.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>11</sub>

------

---

| | |
|:---|:---|
| OTHER INFORMATION | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Cash Flow**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended 31 December** | **Nine Months Ended 31 December** | **Nine Months Ended 31 December** | **Nine Months Ended 31 December** |
| **US$ Millions** | **FY26** | **FY25** | **Change** | **Change %** |
| Net cash provided by operating activities | $455.4 | $657.4 | $(202.0) | (31) |
| Net cash used in investing activities | (4120.5) | (353.1) | 3767.4 | NM |
| Net cash provided by (used in) financing activities | 3436.2 | (163.7) | 3599.9 | NM |

---

Significant sources and uses of cash during fiscal year 2026 include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash provided by operating activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Net income, adjusted for non-cash items, of US$535.7 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Working capital decreased, excluding the assets and liabilities acquired on the AZEK acquisition date, increasing operating cashflow by US$32.5 million, primarily due to lower accounts receivable in North America resulting from lower net sales, partially offset by higher inventories in North America and lower accounts payables.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Asbestos claims and handling costs paid of US$86.8 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash used in investing activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Cash consideration for AZEK acquisition of US$3,919.8 million (net of cash acquired)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Capital expenditures of US$302.8 million, including global capacity expansion project spend of US$72.0 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Proceeds from the sale of our Truganina land of US$108.2 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash provided by financing activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Proceeds from our Term Facilities of US$2.5 billion and our Notes of US$1.7 billion. These proceeds were used to complete the AZEK acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Proceeds from our Revolving Facility of US$70.0 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Repayment of the 2026 senior unsecured notes of US$465.2 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Repayments of US$312.5 million on our term loans

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Debt issuance costs paid of US$41.6 million

**Capital Expenditures**

Our capital expenditures program is driven by strategic investments that support long-term growth and operational excellence. These priorities include adding new capacity ahead of anticipated demand, funding new product development and other strategic initiatives, and maintaining and reinvesting in our existing facilities and equipment.

For fiscal year 2026, we expect total capital expenditures of approximately US$400 million, inclusive of approximately US$75 million related to AZEK initiatives. Spending associated with our Global Capacity Expansion program is projected to be approximately US$90 million of the fiscal year 2026 total.

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>12</sub>

------

---

| | |
|:---|:---|
| OTHER INFORMATION | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Liquidity**

At 31 December 2025, we had US$344.2 million in cash and cash equivalents, a decrease of US$218.5 million from 31 March 2025. We also have US$920.7 million of available borrowing capacity under our revolving credit facility at 31 December 2025.

Our gross debt balance increased from US$1,124.0 million at 31 March 2025 to US$4,648.1 million at 31 December 2025, primarily driven by our new Notes of US$1.7 billion and new Term Facilities of US$2.5 billion, partially offset by the paydown of our term loan of US$290.6 million in April 2025 and our voluntary redemption of our €400.0 million senior unsecured notes in December 2025. Our net debt balance was US$4,303.9 million at 31 December 2025.

During fiscal year 2026, we will contribute A$193.6 million to AICF, excluding interest, in quarterly installments. The first three payments of A$48.4 million were made 1 July 2025, 1 October 2025 and 2 January 2026.

Based on our existing cash balances, together with anticipated operating cash flows and unutilized credit facilities, we anticipate we will have sufficient funds to meet our planned working capital and other expected cash requirements for the next twelve months.

**Capital Allocation**

Our Capital Allocation framework prioritizes the use of free cash flow as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Invest in organic growth

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reduce balance sheet leverage in line with our stated commitments

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Return capital to shareholders

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evaluate tuck-in opportunities to bolster capabilities in railing & recycling

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>13</sub>

------

---

| | |
|:---|:---|
| NON-GAAP FINANCIAL TERMS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Non GAAP Financial Terms**

This Management's Analysis of Results includes certain financial information to supplement the Company's condensed consolidated financial statements which are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These financial measures are designed to provide investors with an alternative method for assessing our performance from on-going operations, capital efficiency and profit generation. Management uses these financial measures for the same purposes. These financial measures include:

**•** Adjusted operating income and adjusted operating income margin **•** Adjusted General Corporate and Unallocated R&D costs

**•** Siding & Trim Segment Adjusted operating income and adjusted operating income margin **•** Adjusted net income and Adjusted diluted earnings per share

**•** Deck, Rail & Accessories Segment Adjusted operating income and adjusted operating income margin **•** Adjusted income before income taxes, Adjusted income tax expense and Adjusted effective tax rate

**•** Australia & New Zealand Segment Adjusted operating income and adjusted operating income margin **•** Net debt

These financial measures are or may be non-GAAP financial measures as defined in the rules of the U.S. Securities and Exchange Commission and may exclude or include amounts that are included or excluded, as applicable, in the calculation of the most directly comparable financial measures calculated in accordance with GAAP. These financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the Company's condensed consolidated financial statements prepared in accordance with GAAP. In evaluating these financial measures, investors should note that other companies reporting or describing similarly titled financial measures may calculate them differently and investors should exercise caution in comparing the Company's financial measures to similar titled measures by other companies.

**Definitions**

**<u>AICF</u> –** Asbestos Injuries Compensation Fund Ltd

**<u>NM</u>** – Not meaningful

**<u>Working Capital</u>** – The working capital calculation used in our cash provided by operating analysis includes the change in: (1) Accounts and other receivables, net; (2) Inventories; and (3) Accounts payable and accrued liabilities

**Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026**<sub>14</sub>

------

---

| | |
|:---|:---|
| NON-GAAP FINANCIAL MEASURES | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**Financial Measures - GAAP equivalents**

**<u>Adjusted operating income and Adjusted operating income margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Operating income** | $**176.2** | $**206.1** | $**338.8** | $**593.8** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.9 |
| Restructuring, net | (24.0) |  | (24.0) | 57.3 |
| Acquisition related expenses | 29.4 |  | 189.1 |  |
| Inventory fair value adjustment |  |  | 47.9 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  | 106.3 |  |
| **Adjusted operating income** | $**239.9** | $**207.0** | $**660.7** | $**654.0** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Operating income margin** | **14.2%** | **21.6%** | **9.9%** | **20.4%** |
| Asbestos related expenses and adjustments | 0.1% | 0.1% | 0.1% | 0.1% |
| Restructuring, net | (2.0)% | —% | (0.7)% | 2.0% |
| Acquisition related expenses | 2.4% | —% | 5.5% | —% |
| Inventory fair value adjustment | —% | —% | 1.4% | —% |
| Amortization of intangible assets resulting from AZEK acquisition | 4.6% | —% | 3.1% | —% |
| **Adjusted operating income margin** | **19.3%** | **21.7%** | **19.3%** | **22.5%** |

---

**<u>Siding & Trim Segment Adjusted operating income and Adjusted operating income margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Siding & Trim Segment operating income** | $**202.9** | $**209.3** | $**515.1** | $**638.5** |
| Acquisition related expenses | 3.6 |  | 8.4 |  |
| Inventory fair value adjustment |  |  | 11.2 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 12.8 |  | 23.6 |  |
| **Siding & Trim Segment Adjusted operating income** | $**219.3** | $**209.3** | $**558.3** | $**638.5** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Siding & Trim Segment operating income margin** | **25.7%** | **29.1%** | **23.5%** | **29.8%** |
| Acquisition related expenses | 0.5% | —% | 0.4% | —% |
| Inventory fair value adjustment | —% | —% | 0.5% | —% |
| Amortization of intangible assets resulting from AZEK acquisition | 1.6% | —% | 1.0% | —% |
| **Siding & Trim Segment Adjusted operating income margin** | **27.8%** | **29.1%** | **25.4%** | **29.8%** |

---

---

| | |
|:---|:---|
| **Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026** | **15** |

---

------

---

| | |
|:---|:---|
| NON-GAAP FINANCIAL MEASURES | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**<u>Deck, Rail & Accessories Segment Adjusted operating income and Adjusted operating income margin</u>**

---

| | | |
|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **FY26** |
| **Deck, Rail & Accessories Segment operating loss** | $**(24.0)** | $**(35.9)** |
| Restructuring expenses | 2.2 | 2.2 |
| Inventory fair value adjustment |  | 36.7 |
| Amortization of intangible assets resulting from AZEK acquisition | 44.8 | 82.7 |
| **Deck, Rail & Accessories Segment Adjusted operating income** | $**23.0** | $**85.7** |

---

---

| | | |
|:---|:---|:---|
| | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **FY26** |
| **Deck, Rail & Accessories Segment operating loss margin** | **(12.4)%** | **(8.0)%** |
| Restructuring expenses | 1.1% | 0.5% |
| Inventory fair value adjustment | —% | 8.1% |
| Amortization of intangible assets resulting from AZEK acquisition | 23.1% | 18.4% |
| **Deck, Rail & Accessories Segment Adjusted operating income margin** | **11.8%** | **19.0%** |

---

**<u>Australia & New Zealand Segment Adjusted operating income and Adjusted operating income margin</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Australia & New Zealand Segment operating income** | $**35.6** | $**34.8** | $**111.4** | $**68.0** |
| Restructuring expenses |  |  |  | 57.3 |
| **Australia & New Zealand Segment Adjusted operating income** | $**35.6** | $**34.8** | $**111.4** | $**125.3** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Australia & New Zealand Segment operating income margin** | **28.1%** | **29.3%** | **29.2%** | **17.2%** |
| Restructuring expenses | —% | —% | —% | 13.9% |
| **Australia & New Zealand Segment Adjusted operating income margin** | **28.1%** | **29.3%** | **29.2%** | **31.1%** |

---

**<u>Adjusted General Corporate and Unallocated R&D Costs</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **General Corporate and Unallocated R&D costs** | $**47.4** | $**41.6** | $**289.7** | $**137.4** |
| Restructuring gain | 26.2 |  | 26.2 |  |
| Acquisition related expenses | (25.8) |  | (180.7) |  |
| Asbestos related expenses and adjustments | (0.7) | (0.9) | (2.6) | (2.9) |
| **Adjusted General Corporate and Unallocated R&D costs** | $**47.1** | $**40.7** | $**132.6** | $**134.5** |

---

---

| | |
|:---|:---|
| **Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026** | **16** |

---

------

---

| | |
|:---|:---|
| NON-GAAP FINANCIAL MEASURES | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**<u>Adjusted net income and Adjusted diluted earnings per share</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **US$ Millions, except per share amounts** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Net income** | $**68.7** | $**141.7** | $**75.5** | $**380.4** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 2.6 | 2.9 |
| AICF interest income | (2.4) | (2.7) | (7.4) | (8.5) |
| Restructuring, net | (24.0) |  | (24.0) | 57.3 |
| Pre-close financing costs<sup>1</sup> |  |  | 46.5 |  |
| Acquisition related expenses | 29.4 |  | 189.1 |  |
| Inventory fair value adjustment |  |  | 47.9 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  | 106.3 |  |
| Tax adjustments<sup>2</sup> | 12.2 | 13.7 | (13.4) | 56.1 |
| **Adjusted net income** | $**142.2** | $**153.6** | $**423.1** | $**488.2** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **FY26** | **FY25** |
| **Net income per common share - diluted** | $**0.12** | $**0.33** | $**0.14** | $**0.88** |
| Asbestos related expenses and adjustments |  |  |  | 0.01 |
| AICF interest income |  | (0.01) | (0.01) | (0.02) |
| Restructuring, net | (0.04) |  | (0.04) | 0.13 |
| Pre-close financing costs<sup>1</sup> |  |  | 0.09 |  |
| Acquisition related expenses | 0.05 |  | 0.35 |  |
| Inventory fair value adjustment |  |  | 0.09 |  |
| Amortization of intangible assets resulting from AZEK acquisition | 0.09 |  | 0.20 |  |
| Tax adjustments<sup>2</sup> | 0.02 | 0.04 | (0.03) | 0.13 |
| **Adjusted diluted earnings per share**<sup>3</sup> | $**0.24** | $**0.36** | $**0.79** | $**1.13** |
| 1 Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br>2 Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br>3 Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended 31 December 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended 31 December 2025 and 2024, respectively. | 1 Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br>2 Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br>3 Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended 31 December 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended 31 December 2025 and 2024, respectively. | 1 Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br>2 Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br>3 Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended 31 December 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended 31 December 2025 and 2024, respectively. | 1 Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br>2 Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br>3 Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended 31 December 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended 31 December 2025 and 2024, respectively. | 1 Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br>2 Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, and discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026.<br>3 Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended 31 December 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended 31 December 2025 and 2024, respectively. |

---

---

| | |
|:---|:---|
| **Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026** | **17** |

---

------

---

| | |
|:---|:---|
| NON-GAAP FINANCIAL MEASURES | ![jhlogo1.jpg](jhlogo1.jpg) |

---

**<u>Adjusted income before income taxes, Adjusted income tax expense and Adjusted effective tax rate</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **US$ Millions** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** | **Three and Nine Months Ended 31 December** |
| | **Q3 FY26** | **Q3 FY25** | **Q3 FY25** | **FY26** | **FY25** | **FY25** |
| **Income before income taxes** | **110.6** | **$** | **202.3** | **160.3** | **$** | **586.6** |
| Asbestos related expenses and adjustments | 0.7 | 0.9 | 0.9 | 2.6 | 2.9 | 2.9 |
| AICF interest income | (2.4) | (2.7) | (2.7) | (7.4) | (8.5) | (8.5) |
| Restructuring, net | (24.0) |  |  | (24.0) | 57.3 | 57.3 |
| Pre-close financing costs<sup>1</sup> |  |  |  | 46.5 |  |  |
| Acquisition related expenses | 29.4 |  |  | 189.1 |  |  |
| Inventory fair value adjustment |  |  |  | 47.9 |  |  |
| Amortization of intangible assets resulting from AZEK acquisition | 57.6 |  |  | 106.3 |  |  |
| **Adjusted income before income taxes** | **171.9** | **$** | **200.5** | **521.3** | **$** | **638.3** |
| **Income tax expense** | **41.9** | **60.6** | **60.6** | **84.8** | **206.2** | **206.2** |
| Tax adjustments<sup>2</sup> | (12.2) | (13.7) | (13.7) | 13.4 | (56.1) | (56.1) |
| **Adjusted income tax expense** | **29.7** | **$** | **46.9** | **98.2** | **$** | **150.1** |
| Effective tax rate | 37.9% | 30.0% | 30.0% | 52.9% | 35.2% | 35.2% |
| **Adjusted effective tax rate** | **17.3%** | **23.4%** | **23.4%** | **18.8%** | **23.5%** | **23.5%** |
| &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. | &nbsp;&nbsp;&nbsp;<sup>1</sup>Includes pre-close financing interest of US$34.9 million as well as a US$11.6 million non-cash loss on our interest rate swap incurred in the first quarter of fiscal year 2026.<br><sup>2</sup>Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and US$18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. |

---

**<u>Net Debt</u>**

---

| | |
|:---|:---|
| **US$ Millions** | |
| | **31 December**<br>**FY26** |
| Total principal amount of debt | $4648.1 |
| Cash and cash equivalents | (344.2) |
| **Net debt** | $**4303.9** |

---

---

| | |
|:---|:---|
| **Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026** | **18** |

---

------

---

| | |
|:---|:---|
| FORWARD-LOOKING STATEMENTS | ![jhlogo1.jpg](jhlogo1.jpg) |

---

This Management's Analysis of Results contains forward-looking statements. James Hardie Industries plc (the "Company") may from time to time make forward-looking statements in its periodic reports filed with or furnished to the Securities and Exchange Commission, on Forms 20-F and 6-K, in its annual reports to shareholders, in offering circulars, invitation memoranda and prospectuses, in media releases and other written materials and in oral statements made by the Company's officers, directors or employees to analysts, institutional investors, existing and potential lenders, representatives of the media and others. Statements that are not historical facts are forward-looking statements and such forward-looking statements are statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

Examples of forward-looking statements include:

▪ statements about the future integration of AZEK, including its anticipated benefits;

▪ statements about the Company's future performance;

▪ projections of the Company's results of operations or financial condition;

▪ statements regarding the Company's plans, objectives or goals, including those relating to strategies, initiatives, competition, acquisitions, dispositions and/or its products;

▪ expectations concerning the costs associated with the suspension or closure of operations at any of the Company's plants and future plans with respect to any such plants;

▪ expectations concerning the costs associated with the significant capital expenditure projects at any of the Company's plants and future plans with respect to any such projects;

▪ expectations regarding the extension or renewal of the Company's credit facilities including changes to terms, covenants or ratios;

▪ expectations concerning dividend payments and share buy-backs;

▪ statements concerning the Company's corporate and tax domiciles and structures and potential changes to them, including potential tax charges;

▪ statements regarding tax liabilities and related audits, reviews and proceedings;

▪ statements regarding the possible consequences and/or potential outcome of legal proceedings brought against us and the potential liabilities, if any, associated with such proceedings;

▪ expectations about the timing and amount of contributions to AICF, a special purpose fund for the compensation of proven Australian asbestos-related personal injury and death claims;

▪ statements regarding the Company's ability to manage legal and regulatory matters (including but not limited to product liability, environmental, intellectual property and competition law matters) and to resolve any such pending legal and regulatory matters within current estimates and in anticipation of certain third-party recoveries; and

▪ statements about economic or housing market conditions in the regions in which we operate, including but not limited to, the levels of new home construction and home renovations, unemployment levels, changes in consumer income, changes or stability in housing values, the availability of mortgages and other financing, mortgage and other interest rates, housing affordability and supply, the levels of foreclosures and home resales, currency exchange rates, and builder and consumer confidence.

Words such as "believe," "anticipate," "plan," "expect," "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "aim," "will," "should," "likely," "continue," "may," "objective," "outlook" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Readers are cautioned not to place undue reliance on these forward-looking statements and all such forward-looking statements are qualified in their entirety by reference to the following cautionary statements.

Forward-looking statements are based on the Company's current expectations, estimates and assumptions and because forward-looking statements address future results, events and conditions, they, by their very nature, involve inherent risks and uncertainties, many of which are unforeseeable and beyond the Company's control. Such known and unknown risks, uncertainties and other factors may cause actual results, performance or other achievements to differ materially from the anticipated results, performance or achievements expressed, projected or implied by these forward-looking statements. These factors, some of which are discussed under "Risk Factors" in Section 3 of our Form 20-F filed with the Securities and Exchange Commission on 20 May 2025, include, but are not limited to: all matters relating to or arising out of the prior manufacture of products that contained asbestos by current and former Company subsidiaries; required contributions to AICF, any shortfall in AICF funding and the effect of currency exchange rate movements on the amount recorded in the Company's financial statements as an asbestos liability; compliance with and changes in tax laws and treatments; competition and product pricing in the markets in which the Company operates; the consequences of product failures or defects; exposure to environmental, asbestos, putative consumer class action or other legal proceedings; general economic and market conditions; the supply and cost of raw materials; possible increases in competition and the potential that competitors could copy the Company's products; compliance with and changes in environmental and health and safety laws; risks of conducting business internationally; compliance with and changes in laws and regulations; currency exchange risks; dependence on customer preference and the concentration of the Company's customer base; dependence on residential and commercial construction markets; the effect of adverse changes in climate or weather patterns; use of accounting estimates; the AZEK acquisition; and all other risks identified in the Company's reports filed with Australian, Irish and US securities regulatory agencies and exchanges (as appropriate). The Company cautions you that the foregoing list of factors is not exhaustive and that other risks and uncertainties may cause actual results to differ materially from those referenced in the Company's forward-looking statements. Forward-looking statements speak only as of the date they are made and are statements of the Company's current expectations concerning future results, events and conditions. The Company assumes no obligation to update any forward-looking statements or information except as required by law.

---

| | |
|:---|:---|
| **Management's Analysis of Results: James Hardie - 3rd Quarter Fiscal Year 2026** | **19** |

---

## Exhibit 99.4

![](fy26q3earningspresentati001.jpg)

1 Q3 FY26 EARNINGS PRESENTATION Third Quarter FY26 Earnings Presentation Tuesday, February 10th

------

![](fy26q3earningspresentati002.jpg)

2 Q3 FY26 EARNINGS PRESENTATION Cautionary Note and Use of Non-GAAP Measures This Earnings Presentation contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. James Hardie Industries plc (the "Company") may from time to time make forward-looking statements in its periodic reports filed with or furnished to the Securities and Exchange Commission on Forms 20-F and 6-K, in its annual reports to shareholders, in media releases and other written materials and in oral statements made by the Company's officers, directors or employees to analysts, institutional investors, representatives of the media and others. Words such as "believe," "anticipate," "plan," "expect," "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "aim," "will," "should," "likely," "continue," "may," "objective," "outlook" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. These forward-looking statements are based upon management's current expectations, estimates, assumptions, beliefs and general good faith evaluation of information available at the time the forward-looking statements were made concerning future events and conditions. Readers are cautioned not to place undue reliance on any forward-looking statements or rely upon them as a guarantee of future performance or results or as an accurate indication of the times at or by which any such performance or results will be achieved. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are unforeseeable and beyond the Company's control. Many factors could cause actual results, performance or achievements to be materially different from those expressed or implied in this Earnings Presentation, including, among others, the risks and uncertainties set forth in Section 3 "Risk Factors" in James Hardie's Annual Report on Form 20-F for the year ended March 31, 2025, which include, but are not necessarily limited to risks such as changes in general economic, political, governmental and business conditions globally and in the countries in which the Company does business; changes in interest rates; changes in inflation rates; changes in exchange rates; the level of construction generally; changes in cement demand and prices; changes in raw material and energy prices; changes in business strategy; the AZEK integration and anticipated benefits and various other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. James Hardie assumes no obligation to update or correct the information contained in this Earnings Presentation except as required by law. This Earnings Presentation includes financial measures that are not considered a measure of financial performance under generally accepted accounting principles in the United States (GAAP). These financial measures are designed to provide investors with an alternative method for assessing our performance from on-going operations, capital efficiency and profit generation. Management uses these financial measures for the same purposes. These financial measures are or may be non-GAAP financial measures as defined in the rules of the U.S. Securities and Exchange Commission and may exclude or include amounts that are included or excluded, as applicable, in the calculation of the most directly comparable financial measures calculated in accordance with GAAP. These non-GAAP financial measures should not be considered to be more meaningful than the equivalent GAAP measure. Management has included such measures to provide investors with an alternative method for assessing its operating results in a manner that is focused on the performance of its ongoing operations and excludes the impact of certain legacy items, such as asbestos adjustments, or significant non-recurring items, such as asset impairments, restructuring gain or expenses, acquisition and pre-close financing related costs, as well as adjustments to tax expense. Additionally, management uses such non- GAAP financial measures for the same purposes. However, these non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. For additional information regarding the non-GAAP financial measures presented in this Earnings Presentation, including a reconciliation of each non-GAAP financial measure to the equivalent GAAP measure, see slides titled "Non-GAAP Financial Measures" included in this Earnings Presentation. This Earnings Presentation forms part of a package of information about the Company's results. It should be read in conjunction with the other parts of this package, including the Management's Analysis of Results, Condensed Consolidated Financial Statements and Earnings Release. All comparisons made are vs. the comparable period in the prior fiscal year and amounts presented are in US dollars, unless otherwise noted.

------

![](fy26q3earningspresentati003.jpg)

3 Q3 FY26 EARNINGS PRESENTATION 61% 5% 8% 26% James Hardie At A Glance James Hardie is a leading provider of exterior home and outdoor living solutions $5.3B FY25 REVENUE +11% 5-YEAR NORTH AMERICA REVENUE CAGR $1.4B FY25 ADJ. EBITDA 27.2% FY25 ADJ. EBITDA MARGIN Note: All financials and net sales breakdowns are based on the James Hardie 2025 fiscal year, are inclusive of AZEK Residential net sales and Adjusted EBITDA over the corresponding period, and exclude net sales and EBITDA associated with the exited James Hardie Philippines business. Breakdown percentages might not add up to 100% due to rounding. North America "NA" is reflective of the combined North America segments, Siding & Trim (S&T) and Deck, Rail & Accessories (DR&A). 81% 9% 9% Total Net Sales by Geography North America ANZ Europe NA Net Sales by Product Category Fiber Cement Exteriors NA Net Sales by End-Market 40% New Construction 60% Repair & Remodel PVC Exteriors Fiber Cement Interiors Deck, Rail & Accessories DR&A S&T DR&A S&T

------

![](fy26q3earningspresentati004.jpg)

4 Q3 FY26 EARNINGS PRESENTATION A Leader in Exterior Home & Outdoor Living Solutions A Product Portfolio Consisting of Best-in-Class Brands Across Attractive Categories A Winning Strategy to Drive Profitable Growth in R&R and New Construction The Right Team to Enable Our Growth, Innovation and Continuous Improvement Plans Globally A Robust Financial Profile and Synergy Opportunity Driving Shareholder Value Creation

------

![](fy26q3earningspresentati005.jpg)

5 Q3 FY26 EARNINGS PRESENTATION Strong Progress on Cost & Commercial Synergies Progressing Towards Full Achievement of $125mm of Cost Synergy Target Note: The Company is targeting $125 million in run-rate cost synergies within three years of closing the transaction. Annualized cost synergies exiting FY26 represents ~$30mm of actual anticipated P&L benefit within FY26, concentrated in 2H FY26. The Company is also targeting $500 million in run-rate commercial synergies within five years of closing the AZEK transaction Manufacturing & Procurement Commercial & R&D General & Administrative $125mm Integration Momentum Driving Cost Synergies CONTRACTORS DEALERS RETAILERS HOMEBUILDERS Partnering to Scale on James Hardie Siding & TimberTech® Decking Securing New, Exclusive AZEK Stocking Positions Key Shelf Space Wins, Pro Desk SKUs and In-Store Merchandising Offering A Broader Exteriors Solution to Deepen Exclusivity Partnerships Wins At Each Step of the Value Chain Validate Our Confidence in Achieving Over $500mm of Commercial Synergies Commercial Synergies Across the Value Chain Recent Wins Reinforce Confidence in Exiting FY27 at a ~$125mm Commercial Synergy Revenue Run-Rate

------

![](fy26q3earningspresentati006.jpg)

6 Q3 FY26 EARNINGS PRESENTATION Q3 FY26 Financial Results Results Reflect Strong Contributions From The AZEK Acquisition Offsetting Market Softness in North America Net Sales $1,240mm +30% Adjusted EBITDA $330mm +26% Adjusted EBITDA Margin 26.6% (90bps) Adjusted Diluted EPS $0.24 (31%) YTD Free Cash Flow $261mm (20%) Note: Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS and Free Cash Flow are non-GAAP financial measures. Refer to Non-GAAP Financial Measures for reconciliation to the most comparable GAAP financial measures.

------

![](fy26q3earningspresentati007.jpg)

7 Q3 FY26 EARNINGS PRESENTATION Organic Business Results Note: Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. Refer to Non-GAAP Financial Measures for reconciliation to the most comparable GAAP financial measures. Net Sales $275mm +1% Adjusted EBITDA $64mm +8% Adjusted EBITDA Margin 27.3% +140bps Net Sales $965mm +1% Adjusted EBITDA $266mm +1% Adjusted EBITDA Margin 27.5% ---

------

![](fy26q3earningspresentati008.jpg)

8 Q3 FY26 EARNINGS PRESENTATION $251mm $269mm Cost Inflation & Continued Growth Investments +5% ASP Growth Inorganic Contribution Q3 FY25 R&D Volume Impact Manufacturing & SG&A Costs Price Growth AZEK Exteriors Q3 FY26 Volumes Down (7%) Previously Unallocated Net Sales End Markets Remain Soft But More Stable Than Expected, With Sell-In and Sell-Through Relatively Consistent  Fiber Cement Exteriors volume declined (MSD%)  Single-family exteriors declined (HSD%), primarily due to continued weakness in the South  Multi-family volumes increased +HSD%  Interiors volume declined (DD%)  ASP growth of +5%, with strong core price realization and favorable mix $719mm $788mm +5% ASP Growth Q3 FY25 Volume Price / Mix AZEK Exteriors Q3 FY26 Volumes Down (7%) Organic S&T Net Sales Down (2%) $81mm Inorganic Contribution Siding & Trim (S&T) Positioning for Growth Despite A Challenging Near-Term Market Backdrop Adjusted EBITDA Focused on Driving Cost Savings to Improve Margins and Mitigate Volume & Inflation Headwinds  Unfavorable volume impact, partially offset by ASP growth  Investing in growth and scale while driving continuous improvement in manufacturing & procurement operations through HOS  ~$9mm of previously unallocated R&D costs Note: Refer to Non-GAAP Financial Measures for reconciliation of Adjusted EBITDA to the most comparable GAAP financial measures. S&T R&D expenses increased ~$9 million primarily due to the allocation of R&D costs which were not allocated to our segments prior to the second quarter of fiscal year 2026. The allocation of previously unallocated R&D costs to the segments began July, 1st 2025.

------

![](fy26q3earningspresentati009.jpg)

9 Q3 FY26 EARNINGS PRESENTATION Net Sales Demand Remains Stable With Growth Initiatives Driving Consistent +MSD% Sell-Through Growth  Q3 Net Sales of $194mm, up +2%, primarily driven by price / mix  Strong performance continued for our premium decking, railing, accessories and pergolas offerings Deck, Rail & Accessories (DR&A) DR&A Positioned To Continue Delivering Above Market Growth And Margin Expansion Adjusted EBITDA Strong DR&A Margin Performance, With Runway For Continued Expansion Through Recycling Initiatives  Q3 Adjusted EBITDA of $49mm, with an Adjusted EBITDA margin of ~25%  Net sales growth along with further progress against cost-savings initiatives  Continued investment in marketing initiatives to drive material conversion and profitable share gain Note: All Deck, Rail & Accessories growth comparisons correspond to the quarter ended December 31, 2024, prior to the acquisition of AZEK by James Hardie, unless otherwise stated. Refer to Non-GAAP Financial Measures for reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin to the most comparable GAAP financial measures.

------

![](fy26q3earningspresentati010.jpg)

10 Q3 FY26 EARNINGS PRESENTATION $118mm $127mm +LSD% Volume Increase +MSD% ASP Growth Q3 FY25 Volume Price / Mix FX / Other Q3 FY26 $116mm +LSD% Sales Increase in Local Currency $131mm +MSD% Volume Increase Solid Underlying Price Realization Offset by Mix FX Tailwind Q3 FY25 Volume Price / Mix FX / Other Q3 FY26 $12mm $17mm Volume Growth Driving Improved Cost Absorption Margin Expansion Initiatives Q3 FY25 Sales Growth Operating Costs Q3 FY26 $40mm $41mm Net Sales Increased +7% ~$1mm R&D Allocation Headwind Q3 FY25 Sales Growth Operating Costs Q3 FY26 Australia & New Zealand (ANZ) Europe Net Sales ANZ Net Sales Increased +7% While Residential Construction Backdrop Remains Muted Adjusted EBITDA Strong Profitability Continues with Adj EBITDA Margin of ~33% Despite R&D Allocation Headwind Net Sales Sales Growth Driven by Strong Performance in Fiber Gypsum Products EBITDA Volume Growth & Margin Initiatives Driving Profit Improvement Note: Refer to Non-GAAP Financial Measures for reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin to the most comparable GAAP financial measures. R&D expenses increased primarily due to the allocation of R&D costs which were not allocated to our segments prior to the second quarter of fiscal year 2026. The allocation of previously unallocated R&D costs to the segments began July, 1st 2025.

------

![](fy26q3earningspresentati011.jpg)

11 Q3 FY26 EARNINGS PRESENTATION FY26 Financial Guidance Note: Guidance includes sales and Adjusted EBITDA contribution from AZEK post-acquisition (July 1, 2025 through March 31, 2026). Adjusted EBITDA and Free Cash Flow are non-GAAP measures. Refer to Non-GAAP Financial measures for a discussion of why we are unable to reconcile Adjusted EBITDA and Free Cash Flow guidance to their most comparable GAAP measures. Q4 (Unchanged) FY26 (Updated) FY26 (Previous) Deck, Rail & Accessories Net Sales $337 to 350mm $787 to 800mm $780 to 800mm Adjusted EBITDA $91 to 97mm $219 to 224mm $215 to 225mm Consolidated AZEK Adjusted EBITDA (Q2 – Q4) $114 to 122mm $267 to 275mm $260 to 275mm Adjusted EBITDA $347 to 378mm $1.232 to 1.263bn $1.20 to 1.25bn Free Cash Flow $200mm+ $200mm+ Siding & Trim Net Sales $757 to 802mm $2.953 to 2.998bn $2.925 to 2.995bn Adjusted EBITDA $240 to 263mm $939 to 962mm $920 to 955mm

------

![](fy26q3earningspresentati012.jpg)

12 Q3 FY26 EARNINGS PRESENTATION Cash Flow Continues to Enable Quick Deleverage Path Pro Forma FY26 Deleveraging Actions Q3 FY28 Net Debt (December 31, 2025) ~$4.30bn Debt reduction enabled by strong FCF generation as operating cash flow increases and growth capex requirements remain modest FY26 Adjusted EBITDA ~$1.41bn Solid Adjusted EBITDA growth driven by sales growth and margin expansion through both organic and synergy initiatives Net Leverage Ratio ~3.0x ≤ 2.0x Note: "FY26 Adjusted EBITDA" contemplates the midpoint of FY26 guidance, excluding stock-based compensation expense, and includes AZEK's Residential Q1 FY26 Adjusted EBITDA of ~$127mm. Refer to Non-GAAP Financial measures for a discussion of why we are unable to reconcile Adjusted EBITDA guidance to its most comparable GAAP measures.

------

![](fy26q3earningspresentati013.jpg)

13 Q3 FY26 EARNINGS PRESENTATION Adjusted EBITDA and Adjusted EBITDA margin US$ Millions Q3 FY26 Q3 FY25 Operating income 176.2$206.1$ Asbestos related expenses and adjustments 0.7 0.9 Restructuring, net (24.0) - Acquisition related expenses 29.4 - Amortization of intangible assets resulting from AZEK acquisition 57.6 - Depreciation and amortization 90.0 55.1 Adjusted EBITDA 329.9$262.1$ Q3 FY26 Q3 FY25 Operating income margin 14.2% 21.6% Asbestos related expenses and adjustments 0.1% 0.1% Restructuring, net (2.0%) - Acquisition related expenses 2.4% - Amortization of intangible assets resulting from AZEK acquisition 4.6% - Depreciation and amortization 7.3% 5.8% Adjusted EBITDA margin 26.6% 27.5% Three Months Ended December 31 Three Months Ended December 31 Non-GAAP Financial Measures Adjusted net income and Adjusted diluted earnings per share US$ Millions, except per share amounts Three Months Ended December 31 Q3 FY26 Q3 FY25 Net income 68.7$141.7$ Asbestos related expenses and adjustments 0.7 0.9 AICF interest income (2.4) (2.7) Restructuring, net (24.0) - Acquisition related expenses 29.4 - Amortization of intangible assets resulting from AZEK acquisition 57.6 - Tax adjustments1 12.2 13.7 Adjusted net income 142.2$153.6$ Three Months Ended December 31 Q3 FY26 Q3 FY25 Net income per common share - diluted 0.12$0.33$ Asbestos related expenses and adjustments - - AICF interest income - (0.01) Restructuring, net (0.04) - Acquisition related expenses 0.05 - Amortization of intangible assets resulting from AZEK acquisition 0.09 - Tax adjustments1 0.02 0.04 Adjusted diluted earnings per share2 0.24$0.36$1) Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos, discrete items relating to the AZEK acquisition, and $18.2 million in respect of the ATO settlement agreement incurred in the second quarter of fiscal year 2026. 2) Weighted average common shares outstanding used in computing diluted net income per common share of 583.1 million and 430.9 million for the three months ended December 31, 2025 and 2024, respectively. Weighted average common shares outstanding used in computing diluted net income per common share of 533.9 million and 432.6 million for the nine months ended December 31, 2025 and 2024, respectively. Free Cash Flow US$ Millions FY26 FY25 Net cash provided by operating activities 455.4$657.4$ Purchases of property, plant and equipment (302.8) (333.0) Proceeds from sale of property, plant and equipment 108.2 - Free Cash Flow 260.8$324.4$ Nine Months Ended December 31

------

![](fy26q3earningspresentati014.jpg)

14 Q3 FY26 EARNINGS PRESENTATION US$ Millions Q3 FY26 Deck, Rail & Accessories Segment operating loss (24.0)$ Amortization of intangible assets resulting from AZEK acquisition 44.8 Restructuring expenses 2.2 Depreciation and amortization 25.7 Deck, Rail & Accessories Segment Adjusted EBITDA 48.7$ Q3 FY26 Deck, Rail & Accessories Segment operating loss margin (12.4%) Amortization of intangible assets resulting from AZEK acquisition 23.1% Restructuring expenses 1.1% Depreciation and amortization 13.3% Deck, Rail & Accessories Segment Adjusted EBITDA margin 25.1% Deck, Rail & Accessories Segment Adjusted EBITDA and Adjusted EBITDA margin Three Months Ended December 31 Three Months Ended December 31 US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 Siding & Trim Segment operating income 202.9$209.3$ Acquisition related expenses 3.6 - Amortization of intangible assets resulting from AZEK acquisition 12.8 - Depreciation and amortization 49.3 41.2 Siding & Trim Segment Adjusted EBITDA 268.6$250.5$ Three Months Ended December 31 Q3 FY26 Q3 FY25 Siding & Trim Segment operating income margin 25.7% 29.1% Acquisition related expenses 0.5% - Amortization of intangible assets resulting from AZEK acquisition 1.6% - Depreciation and amortization 6.3% 5.7% Siding & Trim Segment Adjusted EBITDA margin 34.1% 34.8% Siding & Trim Segment Adjusted EBITDA and Adjusted EBITDA margin Non-GAAP Financial Measures US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 Australia & New Zealand Segment operating income 35.6$34.8$ Depreciation and amortization 5.6 4.9 Australia & New Zealand Segment Adjusted EBITDA 41.2$39.7$ Three Months Ended December 31 Q3 FY26 Q3 FY25 Australia & New Zealand Segment operating income margin 28.1% 29.3% Depreciation and amortization 4.5% 4.2% Australia & New Zealand Segment Adjusted EBITDA margin 32.6% 33.5% Australia & New Zealand Segment Adjusted EBITDA and Adjusted EBITDA margin US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 Europe Segment operating income 9.1$3.6$ Depreciation and amortization 7.5 8.3 Europe Segment EBITDA 16.6$11.9$ Three Months Ended December 31 Q3 FY26 Q3 FY25 Europe Segment operating income margin 7.0% 3.1% Depreciation and amortization 5.7% 7.2% Europe Segment EBITDA margin 12.7% 10.3% Europe Segment EBITDA and EBITDA margin

------

![](fy26q3earningspresentati015.jpg)

15 Q3 FY26 EARNINGS PRESENTATION Net Leverage Ratio US$ Millions December 31 FY26 Numerator: Total principal amount of debt 4,648.1$ Less: Cash and cash equivalents (344.2) Add: Finance operating leases 109.0 Total 4,412.9$ Denominator: (Trailing 12 months) Operating income 400.9$ Asbestos related expenses and adjustments 140.2 Restructuring, net (31.0) Acquisition related expenses 205.6 Inventory fair value adjustment 47.9 Amortization of intangible assets resulting from AZEK acquisition 106.3 Depreciation and amortization 283.6 Stock compensation - equity awards 24.5 Acquired Adjusted EBITDA for preceding periods 249.2 Cost synergies 111.9 Total 1,539.1$ Net Leverage ratio 2.87x US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 Income before income taxes 110.6$202.3$ Asbestos related expenses and adjustments 0.7 0.9 AICF interest income (2.4) (2.7) Restructuring, net (24.0) - Acquisition related expenses 29.4 - Amortization of intangible assets resulting from AZEK acquisition 57.6 - Adjusted income before income taxes 171.9$200.5$ Income tax expense 41.9$60.6$ Tax adjustments1 (12.2) (13.7) Adjusted income tax expense 29.7$46.9$ Effective tax rate 37.9% 30.0% Adjusted effective tax rate 17.3% 23.4% Adjusted income before income taxes, Adjusted income tax expense and Adjusted effective tax rate Net Debt US$ Millions December 31 FY26 Total principal amount of debt 4,648.1$ Cash and cash equivalents (344.2) Net debt 4,303.9$ Non-GAAP Financial Measures US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 Interest, net 65.6$3.8$ AICF interest income 2.4 2.7 Adjusted interest, net 68.0$6.5$ Adjusted interest, net 1) Includes tax adjustments related to the amortization benefit of certain US intangible assets, asbestos and discrete items relating to the AZEK acquisition. US$ Millions Three Months Ended December 31 Q3 FY26 Q3 FY25 General Corporate and Unallocated R&D costs (47.4)$(41.6)$ Restructuring gain (26.2) - Acquisition related expenses 25.8 - Asbestos related expenses and adjustments 0.7 0.9 Adjusted General Corporate and Unallocated R&D costs (47.1)$(40.7)$ Depreciation and amortization 1.9 0.7 Adjusted General Corporate and Unallocated R&D EBITDA (45.2)$(40.0)$ Adjusted General Corporate and Unallocated R&D EBITDA

------

![](fy26q3earningspresentati016.jpg)

16 Q3 FY26 EARNINGS PRESENTATION Non-GAAP Financial Measures US$ Millions Q3 FY26 Q3 FY25 James Hardie (Excluding AZEK) operating income 212.3$206.1$ Asbestos related expenses and adjustments 0.7 0.9 Restructuring, net (26.2) - Acquisition related expenses 20.9 - Depreciation and amortization 58.0 55.1 James Hardie (Excluding AZEK) Adjusted EBITDA 265.7$262.1$ Q3 FY26 Q3 FY25 James Hardie (Excluding AZEK) operating income margin 22.0% 21.6% Asbestos related expenses and adjustments 0.1% 0.1% Restructuring, net (2.7%) - Acquisition related expenses 2.2% - Depreciation and amortization 5.9% 5.8% James Hardie (Excluding AZEK) Adjusted EBITDA margin 27.5% 27.5% Three Months Ended December 31 Three Months Ended December 31 Organic James Hardie (Excluding AZEK) Adjusted EBITDA and Adjusted EBITDA margin 1) AZEK Adjusted EBITDA and Adjusted EBITDA margin for the three months ended December 31, 2024 represents AZEK's Residential and total corporate expenses EBITDA presented using James Hardie's basis of presentation. These results were not subject to quarterly review by their auditors. US$ Millions Q3 FY26 Q3 FY25 AZEK operating (loss) income (36.1)$26.3$ Restructuring, net 2.2 - Acquisition related expenses 8.5 - AZEK historical acquisition and divestiture costs - 0.6 Amortization of intangible assets resulting from AZEK acquisition 57.6 - Depreciation and amortization 32.0 32.7 AZEK Adjusted EBITDA 64.2$59.6$ US$ Millions Q3 FY26 Q3 FY25 AZEK operating (loss) income margin (13.1%) 9.7% Restructuring, net 0.8% - Acquisition related expenses 3.1% - AZEK historical acquisition and divestiture costs - 0.2% Amortization of intangible assets resulting from AZEK acquisition 20.9% - Depreciation and amortization 11.6% 12.0% AZEK Adjusted EBITDA margin 23.3% 21.9% Three Months Ended December 31 Three Months Ended December 31 AZEK Adjusted EBITDA and Adjusted EBITDA margin1

------

![](fy26q3earningspresentati017.jpg)

17 Q3 FY26 EARNINGS PRESENTATION Definitions AICF – Asbestos Injuries Compensation Fund Ltd ANZ – Australia and New Zealand ASP – Average net sales price ("ASP") – Total net sales of fiber cement and fiber gypsum products, excluding siding accessory sales, and Deck, Rail & Accessories net sales divided by the total volume of products sold. DR&A – Deck, Rail & Accessories Free Cash Flow – Free Cash Flow ("FCF"), unless otherwise noted, is defined as net cash provided by operating activities less purchases of property, plant and equipment net of proceeds from the sale of property, plant and equipment. HOS – Hardie Operating System MMSF – Million standard feet, where a standard foot is defined as a square foot of 5/16" thickness NA – North America R&R – Repair & Remodel S&T – Siding & Trim TAM – Total Addressable Market LSD – Low Single-Digits MSD – Mid-Single Digits HSD – High Single-Digits DD – Double-Digits LDD – Low Double-Digits

------

## Exhibit 99.5

**Exhibit 99.5**

**James Hardie Industries plc**

**Condensed Consolidated Financial Statements**

**as of and for the Three and Nine Months Ended 31 December 2025**

------

**James Hardie Industries plc**

**Index**

---

| | |
|:---|:---|
| | **Page** |
| <u>[Condensed Consolidated Balance Sheets as of 31 December 2025 and 31 March 2025](#iae2ac95d90ce40739c7e57df6b192e4a_13)</u> | <u>[F-3](#iae2ac95d90ce40739c7e57df6b192e4a_13)</u> |
| <u>[Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended 31 December 2025 and 2024](#iae2ac95d90ce40739c7e57df6b192e4a_16)</u> | <u>[F-4](#iae2ac95d90ce40739c7e57df6b192e4a_16)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows for the Nine Months Ended 31 December 2025 and 2024](#iae2ac95d90ce40739c7e57df6b192e4a_19)</u> | <u>[F-5](#iae2ac95d90ce40739c7e57df6b192e4a_19)</u> |
| <u>[Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three and Nine Months Ended 31 December 2025 and 2024](#iae2ac95d90ce40739c7e57df6b192e4a_22)</u> | <u>[F-7](#iae2ac95d90ce40739c7e57df6b192e4a_22)</u> |
| <u>[Notes to Condensed Consolidated Financial Statements](#iae2ac95d90ce40739c7e57df6b192e4a_28)</u> | <u>[F-8](#iae2ac95d90ce40739c7e57df6b192e4a_28)</u> |

---

------

**James Hardie Industries plc**

**Condensed Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| (Millions of US dollars) | **(Unaudited)**<br>**31 December**<br>**2025** | 31 March<br>2025 |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**344.2** | $562.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and cash equivalents | **5.0** | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and cash equivalents - Asbestos | **25.7** | 37.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted short-term investments - Asbestos | **187.3** | 175.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and other receivables, net | **311.0** | 391.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **665.8** | 347.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **160.2** | 100.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale | **11.3** | 73.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance receivable - Asbestos | **5.8** | 5.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workers' compensation - Asbestos | **2.5** | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **1718.8** | 1701.8 |
| Property, plant and equipment, net | **3095.4** | 2169.0 |
| Operating lease right-of-use-assets | **127.3** | 70.4 |
| Finance lease right-of-use-assets | **106.1** | 2.7 |
| Goodwill | **4822.0** | 193.7 |
| Intangible assets, net | **3526.9** | 145.6 |
| Insurance receivable - Asbestos | **21.5** | 23.2 |
| Workers' compensation - Asbestos | **17.5** | 16.5 |
| Deferred income taxes | **74.7** | 600.4 |
| Deferred income taxes - Asbestos | **272.1** | 284.5 |
| Other assets | **22.2** | 22.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**13804.5** | $5229.9 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $**667.2** | $446.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and employee benefits | **150.7** | 133.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | **31.6** | 21.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | **5.4** | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, current portion | **43.8** | 9.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued product warranties | **11.2** | 7.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **14.4** | 10.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos liability | **127.3** | 119.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Workers' compensation - Asbestos | **2.5** | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | **59.7** | 59.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **1113.8** | 810.2 |
| Long-term debt | **4565.1** | 1110.1 |
| Deferred income taxes | **564.6** | 121.1 |
| Operating lease liabilities | **112.5** | 63.9 |
| Finance lease liabilities | **103.6** | 1.8 |
| Accrued product warranties | **42.5** | 26.9 |
| Asbestos liability | **831.5** | 864.2 |
| Workers' compensation - Asbestos | **17.5** | 16.5 |
| Other liabilities | **56.7** | 53.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | **7407.8** | 3068.4 |
| Commitments and contingencies (Note 10) |  |  |
| Shareholders' equity: |  |  |
| Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 579,883,254 shares issued and outstanding at 31 December 2025 and 429,818,781 shares issued and outstanding at 31 March 2025 | **326.4** | 222.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | **4308.3** | 271.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **1801.2** | 1725.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(39.2)** | (58.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | **6396.7** | 2161.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $**13804.5** | $5229.9 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**James Hardie Industries plc**

**Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars, except per share data) | **2025** | 2024 | **2025** | 2024 |
| Net sales | $**1239.8** | $953.3 | $**3431.9** | $2906.0 |
| Cost of goods sold | **791.6** | 590.9 | **2225.7** | 1773.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | **448.2** | 362.4 | **1206.2** | 1132.2 |
| Selling, general and administrative expenses | **249.7** | 144.7 | **656.6** | 444.4 |
| Research and development expenses | **16.6** | 11.5 | **44.5** | 36.1 |
| Restructuring, net | **(24.0)** |  | **(24.0)** | 57.3 |
| Acquisition related expenses | **29.4** |  | **189.1** |  |
| Asbestos adjustments | **0.3** | 0.1 | **1.2** | 0.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | **176.2** | 206.1 | **338.8** | 593.8 |
| Interest, net | **65.6** | 3.8 | **168.8** | 7.4 |
| Other expense (income), net | **—** |  | **9.7** | (0.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | **110.6** | 202.3 | **160.3** | 586.6 |
| Income tax expense | **41.9** | 60.6 | **84.8** | 206.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $**68.7** | $141.7 | $**75.5** | $380.4 |
| Income per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $**0.12** | $0.33 | $**0.14** | $0.88 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**0.12** | $0.33 | $**0.14** | $0.88 |
| Weighted average common shares outstanding (Millions): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | **579.4** | 429.5 | **529.2** | 431.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | **583.1** | 430.9 | **533.9** | 432.6 |
| Comprehensive income, net of tax: |  |  |  |  |
| Net income | $**68.7** | $141.7 | $**75.5** | $380.4 |
| Currency translation adjustments | **1.1** | (20.0) | **20.6** | (9.7) |
| Cash flow hedges | **(0.4)** |  | **(1.6)** | (0.1) |
| Reclassification of other comprehensive income | **—** |  | **—** | 8.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income | $**69.4** | $121.7 | $**94.5** | $379.1 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**James Hardie Industries plc**

**Condensed Consolidated Statements of Cash Flows (Unaudited)**

---

| | | |
|:---|:---|:---|
| | Nine Months Ended 31 December | Nine Months Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 |
| **Cash Flows From Operating Activities** |  |  |
| Net income | $**75.5** | $380.4 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **330.5** | 156.8 |
| &nbsp;&nbsp;&nbsp;Lease expense | **30.6** | 24.6 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **5.6** | 94.8 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | **29.2** | 17.7 |
| &nbsp;&nbsp;&nbsp;Asbestos adjustments | **1.2** | 0.6 |
| &nbsp;&nbsp;&nbsp;Non-cash restructuring expenses | **1.1** | 40.2 |
| &nbsp;&nbsp;&nbsp;Non-cash interest expense | **6.9** | 1.5 |
| &nbsp;&nbsp;&nbsp;Non-cash charge related to step up of inventory | **47.9** |  |
| &nbsp;&nbsp;&nbsp;Gain on sale of land | **(26.2)** |  |
| &nbsp;&nbsp;&nbsp;Other, net | **33.4** | 17.0 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts and other receivables | **150.6** | 86.4 |
| &nbsp;&nbsp;&nbsp;Inventories | **(77.4)** | (20.5) |
| &nbsp;&nbsp;&nbsp;Operating lease assets and liabilities, net | **(34.4)** | (25.8) |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | **1.6** | (8.6) |
| &nbsp;&nbsp;&nbsp;Insurance receivable - Asbestos | **3.2** | 3.0 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | **(40.7)** | (15.6) |
| &nbsp;&nbsp;&nbsp;Claims and handling costs paid - Asbestos | **(86.8)** | (87.7) |
| &nbsp;&nbsp;&nbsp;Income taxes payable | **3.4** | (10.2) |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities and interest | **0.2** | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by operating activities** | $**455.4** | $657.4 |
| **Cash Flows From Investing Activities** |  |  |
| Purchases of property, plant and equipment | $**(302.8)** | $(333.0) |
| Proceeds from sale of property, plant and equipment | **108.2** |  |
| Capitalized interest | **(6.1)** | (16.7) |
| Cash consideration for The AZEK Company acquisition, net of cash acquired | **(3919.8)** |  |
| Purchase of restricted investments - Asbestos | **(141.7)** | (145.2) |
| Proceeds from restricted investments - Asbestos | **141.7** | 141.4 |
| Other | **—** | 0.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities** | $**(4120.5)** | $(353.1) |
| **Cash Flows From Financing Activities** |  |  |
| Proceeds from senior secured notes | $**1700.0** | $**—** |
| Proceeds from term loans | **2500.0** |  |
| Proceeds from revolving credit facility | **70.0** |  |
| Repayments of term loans | **(312.5)** | (5.6) |
| Repayment of senior unsecured notes | **(465.2)** |  |
| Debt issuance costs paid | **(41.6)** |  |
| Repayment of finance lease obligations | **(2.8)** | (0.9) |
| Shares repurchased | **—** | (149.9) |
| Taxes paid related to net share settlement of equity awards | **(11.7)** | (7.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) financing activities** | $**3436.2** | $(163.7) |
| Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos | $**(1.8)** | $1.1 |
| Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos | **(230.7)** | 141.7 |
| Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period | **605.6** | 415.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period** | $**374.9** | $557.5 |

---

------

**James Hardie Industries plc**

**Condensed Consolidated Statements of Cash Flows (continued) (Unaudited)**

---

| | | |
|:---|:---|:---|
| | Nine Months Ended 31 December | Nine Months Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 |
| **Non-Cash Investing and Financing Activities** |  |  |
| Capital expenditures incurred but not yet paid | $**23.3** | $23.2 |
| Non-cash ROU assets obtained in exchange for new lease liabilities | $**47.9** | $27.2 |
| Non-cash consideration for AZEK acquisition | $**4143.6** | $— |
| **Supplemental Disclosure of Cash Flow Activities** |  |  |
| Cash paid to AICF | $**62.7** | $49.6 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**James Hardie Industries plc**

**Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three Months Ended 31 December 2025 | Three Months Ended 31 December 2025 | Three Months Ended 31 December 2025 | Three Months Ended 31 December 2025 | Three Months Ended 31 December 2025 |
| (Millions of US dollars) | Common<br>Stock | Additional<br>Paid-in<br>Capital | Retained<br>Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Total |
| **Balances as of 30 September 2025** | $**325.9** | $**4303.6** | $**1732.5** | $**(39.9)** | $**6322.1** |
| Net income |  |  | 68.7 |  | 68.7 |
| Other comprehensive income |  |  |  | 0.7 | 0.7 |
| Stock-based compensation |  | 3.4 |  |  | 3.4 |
| Issuance of ordinary shares | 0.5 | 1.3 |  |  | 1.8 |
| **Balances as of 31 December 2025** | $**326.4** | $**4308.3** | $**1801.2** | $**(39.2)** | $**6396.7** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Nine Months Ended 31 December 2025 | Nine Months Ended 31 December 2025 | Nine Months Ended 31 December 2025 | Nine Months Ended 31 December 2025 | Nine Months Ended 31 December 2025 |
| (Millions of US dollars) | Common<br>Stock | Additional<br>Paid-in<br>Capital | Retained<br>Earnings | Accumulated<br>Other<br>Comprehensive<br>Loss | Total |
| **Balances as of 31 March 2025** | $**222.1** | $**271.9** | $**1725.7** | $**(58.2)** | $**2161.5** |
| Net income |  |  | 75.5 |  | 75.5 |
| Other comprehensive income |  |  |  | 19.0 | 19.0 |
| Stock-based compensation |  | 16.7 |  |  | 16.7 |
| Issuance of ordinary shares | 0.8 | 3.4 |  |  | 4.2 |
| Issuance of ordinary shares in connection with the acquisition of The AZEK Company | 103.5 | 3889.0 |  |  | 3992.5 |
| Issuance of stock awards in connection with the acquisition of The AZEK Company |  | 127.3 |  |  | 127.3 |
| **Balances as of 31 December 2025** | $**326.4** | $**4308.3** | $**1801.2** | $**(39.2)** | $**6396.7** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended 31 December 2024 | Three Months Ended 31 December 2024 | Three Months Ended 31 December 2024 | Three Months Ended 31 December 2024 | Three Months Ended 31 December 2024 | Three Months Ended 31 December 2024 |
| (Millions of US dollars) | Common<br>Stock | Additional<br>Paid-in<br>Capital | Retained<br>Earnings | Treasury<br>Stock | Accumulated<br>Other<br>Comprehensive<br>Loss | Total |
| **Balances as of 30 September 2024** | $**221.9** | $**264.1** | $**1540.4** | $**—** | $**(49.6)** | $**1976.8** |
| Net income |  |  | 141.7 |  |  | 141.7 |
| Other comprehensive loss |  |  |  |  | (20.0) | (20.0) |
| Stock-based compensation | 0.2 | 0.1 |  |  |  | 0.3 |
| Issuance of ordinary shares |  | 1.5 |  |  |  | 1.5 |
| **Balances as of 31 December 2024** | $**222.1** | $**265.7** | $**1682.1** | $**—** | $**(69.6)** | $**2100.3** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Nine Months Ended 31 December 2024 | Nine Months Ended 31 December 2024 | Nine Months Ended 31 December 2024 | Nine Months Ended 31 December 2024 | Nine Months Ended 31 December 2024 | Nine Months Ended 31 December 2024 |
| (Millions of US dollars) | Common<br>Stock | Additional<br>Paid-in<br>Capital | Retained<br>Earnings | Treasury<br>Stock | Accumulated<br>Other<br>Comprehensive<br>Loss | Total |
| **Balances as of 31 March 2024** | $**224.7** | $**256.5** | $**1446.0** | $**—** | $**(68.3)** | $**1858.9** |
| Net income |  |  | 380.4 |  |  | 380.4 |
| Other comprehensive loss |  |  |  |  | (1.3) | (1.3) |
| Stock-based compensation | 0.3 | 10.1 |  |  |  | 10.4 |
| Issuance of ordinary shares |  | 1.8 |  |  |  | 1.8 |
| Shares repurchased |  |  |  | (149.9) |  | (149.9) |
| Shares cancelled | (2.9) | (2.7) | (144.3) | 149.9 |  |  |
| **Balances as of 31 December 2024** | $**222.1** | $**265.7** | $**1682.1** | $**—** | $**(69.6)** | $**2100.3** |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements**

**1. Organization and Significant Accounting Policies**

**Nature of Operations**

James Hardie Industries plc ("JHI plc") and its direct and indirect wholly-owned subsidiaries and variable interest entity ("VIE") are collectively referred to as "James Hardie", the "James Hardie Group" or the "Company". The Company manufactures and sells fiber cement, fiber gypsum and cement-bonded building products for interior and exterior building construction applications, primarily in the United States, Australia, Europe and New Zealand. In August 2024, the company ceased manufacturing in the Philippines.

On 1 July 2025, the Company completed its acquisition of The AZEK Company Inc. ("AZEK"), an industry-leading designer and manufacturer of low maintenance and environmentally sustainable outdoor living products, with manufacturing and recycling facilities in the United States.

**Basis of Presentation**

The Company operates on a fiscal year ending 31 March. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the U.S. generally accepted accounting principles ("GAAP") for interim financial information, and in management's opinion, includes all adjustments, consisting of only normal and recurring adjustments, necessary for the fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. Interim financial results are not necessarily indicative of results anticipated for the full fiscal year or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in the Company's Annual Report on Form 20-F for the fiscal year ended 31 March 2025 from which the prior year balance sheet information herein was derived. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosures. Actual results could differ from those estimates. Certain prior period amounts have been reclassified to conform to the current period presentation.

The Company has recorded on its condensed consolidated balance sheets certain foreign assets and liabilities, that are denominated in foreign currencies and subject to translation or remeasurement into US dollars at each reporting date under the applicable accounting guidance. Unless otherwise noted, the Company converts foreign currency denominated assets and liabilities into US dollars at the spot rate at the end of the reporting period; while revenues and expenses are converted using an average exchange rate for the period.

The gains and losses on the remeasurement of the Company's Euro denominated debt are economically offset by foreign exchange gains and losses on loans between subsidiaries, resulting in a net immaterial translation gain or loss which is recorded in the *Selling, general and administrative expenses* in the condensed consolidated statements of operations and comprehensive income.

**Summary of Significant Accounting Policies**

During the nine months ended 31 December 2025, the Company entered into an interest rate swap to manage market risks and reduce exposure resulting from fluctuations in interest rates associated with the new senior secured term facilities by converting a portion of its floating rate debt to fixed rate debt. The Company recognizes all derivative instruments at fair value and classifies them on the condensed consolidated balance sheet as either Other non-current assets or Other current liabilities. The Company

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

estimates the fair value of the interest rate swap using a valuation model based on observable market data, such as yield curves, and as such are classified as Level 2 within the fair value hierarchy. The interest rate swap qualified and was designated as a cash flow hedge on 1 July 2025. The effective portion of the change in fair value of the derivative is recorded as part of *Accumulated other comprehensive loss* and then reclassified into *Interest, net* in the same period in which the hedged transaction affects earnings. The related gains and losses are included as a reconciling item in the reconciliation of net income and net cash flow from operating activities each reporting period. The Company does not use derivatives for trading purposes. Refer to Note 9 "Derivative Instruments" for further details on the Company's derivative instrument.

Other than noted above, there were no changes to our significant accounting policies as described in our Annual Report on Form 20-F for the fiscal year ended 31 March 2025.

**Cash and Cash Equivalents, Restricted Cash and Restricted Cash - Asbestos**

The following table provides a reconciliation of *Cash and cash equivalents, Restricted cash and Restricted cash - Asbestos* reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

---

| | | |
|:---|:---|:---|
| | **31 December** | 31 March |
| (Millions of US dollars) | **2025** | 2025 |
| Cash and cash equivalents | $**344.2** | $562.7 |
| Restricted cash | **5.0** | 5.0 |
| Restricted cash - Asbestos | **25.7** | 37.9 |
| Total | $**374.9** | $605.6 |

---

*Restricted cash* relates to letters of credit with insurance companies, which restrict the cash from use for general corporate purposes.

*Restricted cash - Asbestos* is restricted to the settlement of asbestos claims and for the payment of the operating costs of Asbestos Injuries Compensation Fund ("AICF").

**Earnings Per Share**

Basic earnings per share ("EPS") is calculated using net income divided by the weighted average number of common shares outstanding during the period. Diluted EPS is similar to basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares calculated using the treasury method that would have been outstanding if the dilutive potential common shares, such as stock options and restricted stock units, had been issued.

Basic and diluted common shares outstanding used in determining net income per share are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of shares) | **2025** | 2024 | **2025** | 2024 |
| Basic common shares outstanding | **579.4** | 429.5 | **529.2** | 431.2 |
| Dilutive effect of stock awards | **3.7** | 1.4 | **4.7** | 1.4 |
| Diluted common shares outstanding | **583.1** | 430.9 | **533.9** | 432.6 |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

There were 0.7 million and 0.2 million of potential common shares which would be considered anti-dilutive for the three and nine months ended 31 December 2025, respectively. There were no potential common shares which would be considered anti-dilutive for the three and nine months ended 31 December 2024.

Potential common shares of 1.4 million and 1.1 million for the three and nine months ended 31 December 2025, respectively, and 0.7 million and 0.6 million for the three and nine months ended 31 December 2024, have been excluded from the calculation of diluted common shares outstanding as they are considered contingent shares which are not expected to vest.

Upon the completion of the acquisition of AZEK, the Company issued 148,861,701 shares of common stock on 1 July 2025.

**Accounting Standards Issued But Not Yet Adopted**

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-09, Income Taxes (Topic 740). The amendments in this standard enhance income tax disclosures primarily related to the rate reconciliation and income taxes paid information. These amendments are effective for fiscal years beginning after 15 December 2024, with early adoption permitted. The Company will adopt ASU No. 2023-09 starting with its annual report for the fiscal year ending 31 March 2026 and will be required to make additional disclosures in the notes to the consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The amendments in this standard require disaggregation of specific expense categories in the notes to the financial statements and a qualitative description of the remaining expense amounts not separately disaggregated. These amendments are effective for fiscal years beginning after 15 December 2026, and interim periods within fiscal years beginning after 15 December 2027, with early adoption permitted. The Company plans to adopt ASU No. 2024-03 starting with its annual report for the fiscal year ending 31 March 2028 and is currently evaluating the impact of the guidance to the consolidated financial statements.

**2. Business Combination**

On 1 July 2025, the Company completed the acquisition of AZEK pursuant to the Agreement and Plan of Merger dated 23 March 2025, as amended, ("Merger Agreement") among JHI plc, Juno Merger Sub Inc. and AZEK. As a result of the acquisition, AZEK became a wholly-owned subsidiary of the Company.

The business combination was accounted for under the acquisition method of accounting. Under the acquisition method of accounting, the Company is required to measure identifiable assets acquired, liabilities assumed and any noncontrolling interests in the acquiree at their fair values as of the acquisition date. The Company's accounting for the acquisition is preliminary. The acquisition-date fair value estimates for identifiable assets acquired and liabilities assumed are based on preliminary calculations and allocations, and these estimates and assumptions are subject to change as additional information is obtained during the measurement period, which may be up to one year from the acquisition date.

Pursuant to the Merger Agreement, each outstanding share of AZEK common stock was converted into the right to receive US$26.45 in cash and 1.0340 of James Hardie ordinary shares listed on the New York Stock Exchange. Incorporated into consideration transferred is the fair value of certain employee stock options which were calculated using a Black-Scholes option pricing model, as well as certain employee restricted stock units, which were calculated using the stock price on the transaction date. Finally, the consideration includes the entirety of the US$437.8 million of AZEK debt that was repaid by James Hardie on the acquisition date.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

Our calculation of the consideration transferred is summarized below:

---

| | | |
|:---|:---|:---|
| (Millions of US dollars, except share and per share data) | **Purchase Consideration** | **Purchase Consideration** |
| **Consideration Transferred:** |  |  |
| Total shares of AZEK common stock acquired | 143966912 |  |
| Cash consideration per share of AZEK common stock | $26.45 |  |
| Cash for AZEK common stock | 3807.9 |  |
| Cash settlement of certain stock options | 4.2 |  |
| Cash consideration paid for common stock and stock options |  | $3812.1 |
| AZEK debt repaid as of the acquisition date |  | 437.8 |
| **Total cash consideration paid** |  | $**4249.9** |
| Total shares of AZEK common stock acquired | 143966912 |  |
| Exchange ratio | 1.034 |  |
| James Hardie Ordinary Shares issued | 148861787 |  |
| Per share price of James Hardie ordinary shares on 1 July 2025 | $26.82 |  |
| Fair value of consideration of James Hardie ordinary shares |  | 3992.5 |
| Fair value of James Hardie equity awards to be issued in exchange for certain AZEK equity awards |  | 151.1 |
| **Total consideration transferred** |  | $**8393.5** |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

The following table summarizes the allocation of the purchase price to the identifiable assets acquired and liabilities assumed, based on their estimated fair values as of the acquisition date. The purchase price allocation was based on preliminary valuations and is subject to revisions as more detailed analyses are completed and additional information about the fair value of assets acquired and liabilities assumed become available.

---

| | |
|:---|:---|
| (Millions of US dollars) | **Assets Acquired and<br>Liabilities Assumed** |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $330.1 |
| &nbsp;&nbsp;&nbsp;Accounts and other receivables | 60.6 |
| &nbsp;&nbsp;&nbsp;Inventories | 280.0 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 60.3 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment | 838.2 |
| &nbsp;&nbsp;&nbsp;Intangible assets | 3480.0 |
| &nbsp;&nbsp;&nbsp;Other assets - non-current | 134.8 |
| Total assets acquired | $5184.0 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $211.6 |
| &nbsp;&nbsp;&nbsp;Other liabilities - current | 73.9 |
| &nbsp;&nbsp;&nbsp;Deferred tax liabilities, net | 967.3 |
| &nbsp;&nbsp;&nbsp;Other liabilities - non-current | 149.9 |
| Total liabilities assumed | $1402.7 |
| Net assets acquired | $3781.3 |
| Amount of goodwill recognized | $4612.2 |
| **Total consideration transferred** | $**8393.5** |

---

The Company has completed the preliminary valuation analyses necessary to assess the fair values of the assets acquired and liabilities assumed and the amount of goodwill to be recognized as of the acquisition date. These fair values were based on management's estimates and assumptions; however, the amounts indicated above are preliminary in nature and are subject to adjustment as additional information is obtained and evaluated about the facts and circumstances that existed as of the acquisition date. Accordingly, there may be adjustments to the assigned values. The primary areas that remain preliminary include, but are not limited to, intangible assets including the preliminary assumptions used in their estimates of fair values and their respective estimated useful lives, the valuation of property, plant and equipment, real estate leases, certain tangible assets, income taxes, and residual goodwill. The final determination of the fair values, purchase consideration, related income tax impacts and residual goodwill will be completed as soon as practicable, and within the measurement period of up to one year from the acquisition date as permitted under GAAP. Any adjustments to provisional amounts that are identified during the measurement period will be recorded in the reporting period in which the adjustment is determined.

Goodwill of US$4,612.2 million arising from the acquisition is calculated as the excess of the purchase price over the net assets acquired and is attributable to expected synergies, expanded market opportunities, and enhanced delivery network capabilities. Goodwill related to this acquisition is expected to be nondeductible for tax purposes. As the valuation is preliminary, we have not yet finalized the assignment of goodwill to our reporting units, and no goodwill currently resides in our reportable segments. See Note 6 "Goodwill and Other Intangible Assets" for more information.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

As described in more detail in Note 15 "Segment Information", the Company changed its segment reporting structure to reflect its new organizational structure commencing with the quarter ended 30 September 2025. Under the revised reporting structure, the legacy North America Fiber Cement segment was integrated with the acquired AZEK Exteriors business to form a new segment called Siding & Trim. Additionally, the Company created a Deck, Rail & Accessories segment which includes the remainder of the acquired AZEK business. The newly named Australia & New Zealand segment consists of the legacy Asia Pacific Fiber Cement segment, while the newly named Europe segment consists of the legacy Europe Building Products segment.

During the three and nine months ended 31 December 2025, the Company recorded acquisition-related costs as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Acquisition related expenses* line item in the condensed consolidated statements of operations and comprehensive income statement of US$29.4 million and US$189.1 million for the three and nine months ended 31 December 2025, respectively, includes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ US$94.7 million of transaction costs for the nine months ended 31 December 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ US$29.4 million and US$94.4 million of integration costs for the three and nine months ended 31 December 2025, respectively.

**AZEK Results**

AZEK results for the post acquisition period 1 July 2025 through 31 December 2025 were as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended<br>31 December 2025 | Nine Months Ended<br>31 December 2025 |
| (Millions of US dollars) | (unaudited) | (unaudited) |
| Net sales | $275.0 | $620.1 |
| Net loss | $(64.1) | $(112.9) |

---

Included in the results of AZEK was a one-time increase in *Cost of goods sold* of US$47.9 million inventory step-up adjustment for the nine months ended 31 December 2025. Also included in the results is additional amortization of US$57.6 million and US$106.3 million for the three and nine months ended 31 December 2025, respectively, resulting from the recognition of identified finite-lived intangible assets resulting from the preliminary purchase price accounting and acquisition related costs of US$8.5 million and US$46.5 million, respectively.

**Supplemental Pro Forma Results of Operations** 

The following unaudited supplemental pro forma financial information presents our consolidated results of operations as if the acquisition had been completed on 1 April 2024, but using the fair values of the assets acquired and liabilities assumed as of the closing date of the merger. This pro forma presentation does not include any impact of transaction synergies. The pro forma results are not necessarily indicative of our results of operations that actually would have been achieved had the acquisition been completed on the assumed date, nor are they necessarily indicative of future results.

---

| | | |
|:---|:---|:---|
| | Nine Months Ended 31 December | Nine Months Ended 31 December |
| (Millions of US dollars) | 2025<br>(Unaudited) | 2024<br>(Unaudited) |
| Net sales | $3864.2 | $3974.0 |
| Net income | $60.2 | $345.8 |

---

The pro forma results include adjustments directly attributable to the business combination. The adjustments relate to purchase accounting, primarily amortization of intangible assets and the impact of

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

the acquisition financing. Included in the results for the nine months ended 31 December 2025 are acquisition related expenses of US$189.1 million.

**3. Revenues**

The Company's presentation of revenue by reportable segment most reasonably depicts how the nature, amount, timing and uncertainty of the Company's revenue and cash flows are affected by economic and market-specific factors. The Company recognizes revenues when the requisite performance obligation has been met, that is, when the Company transfers control of its products to customers per the arranged shipping terms, which are generally on delivery.

The following represents the Company's disaggregated revenues:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 | **2025** | 2024 |
| Siding & Trim | $**788.3** | $719.3 | $**2196.1** | $2144.4 |
| Deck, Rail & Accessories | **194.1** |  | **449.9** |  |
| Australia & New Zealand | **126.5** | 118.1 | **381.0** | 401.8 |
| Europe | **130.9** | 115.9 | **404.9** | 359.8 |
| Total | $**1239.8** | $953.3 | $**3431.9** | $2906.0 |

---

The process by which the Company recognizes revenues is similar across each of the Company's reportable segments. The Company records estimated reductions in sales for customer rebates and discounts including volume, promotional, cash and other discounts. Rebates and discounts are recorded in *Net sales* based on management's best estimate when products are sold. The estimates are based on historical experience for similar programs and products, and contractual obligations. Management reviews these rebates and discounts on an ongoing basis and the related accruals are adjusted, if necessary, as additional information becomes available.

**4. Inventories**

*Inventories* consist of the following components:

---

| | | |
|:---|:---|:---|
| | **31 December** | 31 March |
| (Millions of US dollars) | **2025** | 2025 |
| Finished goods | $**490.6** | $243.9 |
| Work-in-process | **51.0** | 26.5 |
| Raw materials and supplies | **140.3** | 87.4 |
| Provision for obsolete finished goods and raw materials | **(16.1)** | (10.7) |
| Total | $**665.8** | $347.1 |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

**5. Property, Plant and Equipment**

Property, plant and equipment consist of the following components:

---

| | | |
|:---|:---|:---|
| | **31 December** | 31 March |
| (Millions of US dollars) | **2025** | 2025 |
| Land | $**120.5** | $94.7 |
| Buildings | **961.4** | 747.0 |
| Machinery and equipment | **3147.6** | 2316.2 |
| Construction in progress | **580.7** | 532.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, at cost | **4810.2** | 3689.9 |
| Less accumulated depreciation | **(1714.8)** | (1520.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | $**3095.4** | $2169.0 |

---

Depreciation expense for the three and nine months ended 31 December 2025 was US$86.3 million and US$215.7 million, respectively. Depreciation expense for the three and nine months ended 31 December 2024 was US$54.0 million and US$153.0 million, respectively.

**6. Goodwill and Other Intangible Assets**

<u>Goodwill</u>

The following are the changes in the carrying value of goodwill:

---

| | | | |
|:---|:---|:---|:---|
| (Millions of US dollars) | Europe | General Corporate <sup>1</sup> | Total |
| Balance - 31 March 2025 | $193.7 | $— | $193.7 |
| Foreign exchange impact | 16.1 |  | 16.1 |
| Acquisition of The AZEK Company |  | 4612.2 | 4612.2 |
| Balance - 31 December 2025 | $209.8 | $4612.2 | $4822.0 |
| <sup>1</sup> The valuation of the AZEK acquisition is preliminary, and the assignment of goodwill to our reportable segments is not yet finalized. As such no goodwill from the AZEK acquisition currently resides in our reportable segments. | <sup>1</sup> The valuation of the AZEK acquisition is preliminary, and the assignment of goodwill to our reportable segments is not yet finalized. As such no goodwill from the AZEK acquisition currently resides in our reportable segments. | <sup>1</sup> The valuation of the AZEK acquisition is preliminary, and the assignment of goodwill to our reportable segments is not yet finalized. As such no goodwill from the AZEK acquisition currently resides in our reportable segments. | <sup>1</sup> The valuation of the AZEK acquisition is preliminary, and the assignment of goodwill to our reportable segments is not yet finalized. As such no goodwill from the AZEK acquisition currently resides in our reportable segments. |

---

<u>Intangible Assets</u>

The following are the net carrying amount of indefinite lived intangible assets other than goodwill:

---

| | | |
|:---|:---|:---|
| | **31 December** | 31 March |
| (Millions of US dollars) | **2025** | 2025 |
| Trade names | $**121.0** | $111.6 |
| Other | **7.4** | 7.4 |
| Total | $**128.4** | $119.0 |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

The following are the net carrying amount of amortizable intangible assets:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | 31 December 2025 | 31 December 2025 | 31 December 2025 |
| (Millions of US dollars) | Lives in Years | Gross Carrying<br>Amount | Accumulated<br>Amortization | Net Carrying<br>Amount |
| Customer Relationships | 2 to 18 | $2991.5 | $(108.4) | $2883.1 |
| Trade names | 5 to 15 | 330.0 | (14.1) | 315.9 |
| Technology | 10 | 210.0 | (10.5) | 199.5 |
| Total |  | $3531.5 | $(133.0) | $3398.5 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | 31 March 2025 | 31 March 2025 | 31 March 2025 |
| (Millions of US dollars) | Lives in Years | Gross Carrying<br>Amount | Accumulated<br>Amortization | Net Carrying<br>Amount |
| Customer Relationships | 2 to 13 | $47.5 | $(20.9) | $26.6 |
| Total |  | $47.5 | $(20.9) | $26.6 |

---

The amortization of intangible assets was US$59.1 million and US$110.1 million for the three and nine months ended 31 December 2025, respectively. The amortization of intangible assets was US$1.1 million and US$3.3 million for the three and nine months ended 31 December 2024, respectively. As of 31 December 2025, the remaining weighted average amortization period for acquired intangible assets was 17.0 years.

**7. Debt**

The Company's debt obligations are as follows:

---

| | | |
|:---|:---|:---|
| | **31 December** | 31 March |
| (Millions of US dollars) | **2025** | 2025 |
| **Unsecured debt:** |  |  |
| &nbsp;&nbsp;&nbsp;5.000% Senior notes due 2028 | $**400.0** | $400.0 |
| &nbsp;&nbsp;&nbsp;3.625% Senior notes due 2026 (€400.0 million) | **—** | 433.4 |
| &nbsp;&nbsp;&nbsp;Term Loan due 2028 | **—** | 290.6 |
| **Secured debt:** |  |  |
| &nbsp;&nbsp;&nbsp;5.875% Senior notes due 2031 | **700.0** |  |
| &nbsp;&nbsp;&nbsp;6.125% Senior notes due 2032 | **1000.0** |  |
| &nbsp;&nbsp;&nbsp;Revolving Facility | **70.0** |  |
| &nbsp;&nbsp;&nbsp;Term A-1 Facility, due 2028 | **750.0** |  |
| &nbsp;&nbsp;&nbsp;Term A-2 Facility, due 2030 | **1728.1** |  |
| Unamortized debt issuance costs | **(39.2)** | (4.5) |
| Total debt | **4608.9** | 1119.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less current portion | **(43.8)** | (9.4) |
| **Total Long-term debt** | $**4565.1** | $1110.1 |
| Weighted average interest rate of total debt | **5.6%** | 4.8% |
| Fair value of Senior unsecured notes (Level 1) | $**400.0** | $817.7 |
| Fair value of Senior secured notes (Level 1) | $**1739.8** | $— |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

As of 31 December 2025, the carrying value of the Company's Credit Facilities, as discussed below, of US$2,548.1 million approximates fair value, as the interest rate is variable and reflects current market rates.

<u>Debt Facilities - Terminated</u>

The following debt facilities were terminated during the nine months ended 31 December 2025, and the remaining associated debt issuance costs of US$33.6 million were written off to interest expense. Included in the write off were remaining Bridge Commitment costs of US$31.5 million which were classified as *Prepaid expenses and other current assets* as of 31 March 2025.

*2026 Senior Unsecured Notes*

In December 2025, the Company redeemed the €400.0 million aggregate principal amount (US$465.2 million, based on the exchange rate at 10 December 2025) of the 2026 senior unsecured notes.

*Term Loan Agreement ("TLA")*

In April 2025, the Company used existing cash resources to pay off the outstanding balance on its TLA totaling US$290.6 million.

*Unsecured Revolving Credit Facility*

In May 2025, the Company terminated its undrawn US$600.0 million unsecured revolving credit facility.

*Bridge Commitment*

In June 2025, the Company cancelled its 364-day Bridge Commitment in conjunction with establishing the new facilities noted below.

<u>Debt Facilities - New</u>

*Senior Secured Credit Facilities*

In May 2025, James Hardie International Group Limited ("JHIGL"), JH North America Holdings Inc. ("JHNAH"), James Hardie International Finance Designated Activity Company ("JHIF"), James Hardie US Holdings Limited ("JHUSHL") and James Hardie Building Products Inc. ("JHBP") entered into a Credit and Guaranty Agreement (the "Credit Agreement"), with Bank of America, N.A. ("BofA"), as administrative and collateral agent.

The Credit Agreement provides for senior secured credit facilities (the "Credit Facilities") in an aggregate principal amount of US$3.5 billion, with terms as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a senior secured term "A" loan facility in an aggregate principal amount of US$750 million (the "Term A-1 Facility"), maturing 30 May 2028 with interest at a Term Secured Overnight Financing Rate ("SOFR") plus a margin varying from 1.25% to 1.875%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a senior secured term "A" loan facility in an aggregate principal amount of US$1.75 billion (the "Term A-2 Facility" and, together with the Term A-1 Facility, the "Term Facilities"), maturing 30 May 2030 with interest at a Term SOFR plus a margin varying from 1.375% to 2.00%; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a senior secured revolving credit facility in an aggregate principal amount of US$1.0 billion (the "Revolving Facility"), which includes a US$100 million sublimit for the issuance of letters of credit and a US$50 million sublimit for the borrowing of swing line loans, maturing 30 May 2030. Interest

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

on the Revolving Facility will be at a Term SOFR plus a margin varying from 1.375% to 2.00%, and unutilized commitments are subject to a per annum fee ranging from 0.20% to 0.30%.

Debt issuance costs incurred in connection with the Credit Facilities are recorded as an offset to *Long-term debt* on the Company's condensed consolidated balance sheet as of 31 December 2025. These costs are being amortized as interest expense using the effective interest method over the stated terms.

On 1 July 2025, the Company drew down the entire US$2.5 billion on the Term Facilities to fund a portion of the cash consideration for the AZEK acquisition.

*2031 and 2032 Senior Secured Notes*

In June 2025, JHNAH completed its private offering of US$1.7 billion aggregate principal amount of senior secured notes (the "Notes"). The Notes were issued at par with US$700 million due 31 January 2031 (the "2031 Notes") and the remaining US$1.0 billion due 31 July 2032 (the "2032 Notes"). The 2031 Notes bear interest at a rate of 5.875% per annum and the 2032 Notes bear interest at a rate of 6.125% per annum.

The Company used the net proceeds from the Notes, together with proceeds of the Term Facilities and cash on hand, to (i) finance the aggregate cash consideration of the acquisition of AZEK (ii) to repay and terminate AZEK's existing debt and (iii) to pay fees and expenses related to the acquisition.

Debt issuance costs incurred in connection with the 2031 and 2032 Notes are recorded as an offset to *Long-term debt* on the Company's condensed consolidated balance sheet as of 31 December 2025. These costs are being amortized as interest expense using the effective interest method over the stated terms.

The indenture governing the 2031 and 2032 Notes contains covenants that limit the ability of the Company and any of its restricted subsidiaries, to, among other things: create liens on certain assets to secure debt and to enter into certain sale-leaseback transactions. The Credit Facilities contain certain covenants that, among other things, restrict JHIGL and its restricted subsidiaries' ability to incur indebtedness and grant liens other than certain types of permitted indebtedness and permitted liens, make certain restricted payments, and undertake certain types of mergers or consolidation actions.

The obligations under the Credit Facilities and Notes are (i) jointly and severally guaranteed on a senior secured basis by JHIGL, JHNAH, JHIF, JHUSHL and JHBP and; (ii) are secured by a lien on the equity interests of certain direct wholly owned material US restricted subsidiaries of JHIGL and the borrowers that are not restricted from being pledged pursuant to applicable regulatory requirements or applicable law.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

At 31 December 2025, the Company's debt maturities for the next five fiscal years and thereafter are as follows:

---

| | |
|:---|:---|
| (Millions of US dollars) | Amount |
| Fiscal 2026 | $10.9 |
| Fiscal 2027 | 43.8 |
| Fiscal 2028 | 476.6 |
| Fiscal 2029 | 837.5 |
| Fiscal 2030 | 87.5 |
| Thereafter | 3191.8 |
| &nbsp;&nbsp;&nbsp;Total | $4648.1 |

---

As of 31 December 2025, the Company was in compliance with all of its covenants contained in the senior unsecured notes, Senior Secured Credit Facilities and Senior Secured Notes.

<u>Off Balance Sheet Arrangements</u>

As of 31 December 2025, the Company had US$70.0 million outstanding borrowings under the Revolving Facility and had US$9.3 million of issued but undrawn letters of credit and bank guarantees. These letters of credit and bank guarantees relate to various operational matters including insurance, performance bonds and other items, leaving the Company with US$920.7 million of available borrowing capacity under the Revolving Facility.

**8. Asbestos**

The following is a detailed rollforward of the Net Unfunded Amended and Restated Final Funding Agreement ("AFFA") liability, net of tax, for the nine months ended 31 December 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| (Millions of US dollars) | Asbestos<br>Liability | Insurance<br>Receivables | Restricted<br>Cash and Investments | Other <br>Assets <br>and Liabilities | Net Unfunded AFFA Liability | Deferred Tax<br>Assets | Income<br>Tax<br>Payable | Net Unfunded AFFA Liability, net of tax |
| Opening Balance - 31 March 2025 | $(983.6) | $28.7 | $213.7 | $0.7 | $(740.5) | $284.5 | $37.9 | $(418.1) |
| Asbestos claims paid | 85.7 |  | (85.7) |  |  |  |  |  |
| Payment received in accordance with AFFA |  |  | 62.7 |  | 62.7 |  |  | 62.7 |
| AICF claims-handling costs incurred (paid) | 1.1 |  | (1.1) |  |  |  |  |  |
| AICF operating costs paid - non claims-handling |  |  | (1.4) |  | (1.4) |  |  | (1.4) |
| Insurance recoveries |  | (3.2) | 3.2 |  |  |  |  |  |
| Movement in income taxes |  |  |  |  |  | (28.4) | (10.3) | (38.7) |
| Other movements |  |  | 8.6 | (0.3) | 8.3 | (1.8) |  | 6.5 |
| Effect of foreign exchange | (62.0) | 1.8 | 13.0 | 0.1 | (47.1) | 17.8 | 1.5 | (27.8) |
| **Closing Balance - 31 December 2025** | $**(958.8)** | $**27.3** | $**213.0** | $**0.5** | $**(718.0)** | $**272.1** | $**29.1** | $**(416.8)** |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

*Claims Data*

The following table shows the activity related to the numbers of open claims, new claims and closed claims during each of the past five years and the average settlement per settled claim and case closed:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | For the Years Ended 31 March | For the Years Ended 31 March | For the Years Ended 31 March | For the Years Ended 31 March | For the Years Ended 31 March |
| | **Nine Months**<br>**Ended**<br>**31 December 2025** | 2025 | 2024 | 2023 | 2022 | 2021 |
| Number of open claims at beginning of period | **482** | 379 | 359 | 365 | 360 | 393 |
| Number of new claims |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Direct claims | **267** | 443 | 410 | 403 | 411 | 392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross claims | **110** | 210 | 154 | 152 | 144 | 153 |
| Number of closed claims | **436** | 550 | 544 | 561 | 550 | 578 |
| Number of open claims at end of period | **423** | 482 | 379 | 359 | 365 | 360 |
| Average settlement amount per settled claim | **A$310,000** | A$327,000 | A$289,000 | A$303,000 | A$314,000 | A$248,000 |
| Average settlement amount per case closed <sup>1</sup> | **A$257,000** | A$291,000 | A$262,000 | A$271,000 | A$282,000 | A$225,000 |
| Average settlement amount per settled claim | **US$202,000** | US$213,000 | US$190,000 | US$208,000 | US$232,000 | US$178,000 |
| Average settlement amount per case closed <sup>1</sup> | **US$167,000** | US$190,000 | US$172,000 | US$186,000 | US$208,000 | US$162,000 |
| <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. | <sup>1</sup> The average settlement amount per case closed includes nil settlements. |

---

Under the terms of the AFFA, the Company has rights of access to actuarial information produced for AICF by the actuary appointed by AICF, which is currently KPMG. The Company's disclosures with respect to claims statistics are subject to it obtaining such information, however, the AFFA does not provide the Company an express right to audit or otherwise require independent verification of such information or the methodologies to be adopted by the approved actuary. As such, the Company relies on the accuracy and completeness of the information provided by AICF to the approved actuary and the resulting information and analysis of the approved actuary when making disclosures with respect to claims statistics.

*AICF Funding*

During fiscal year 2026, the Company will contribute A$193.6 million to AICF, excluding interest, in quarterly installments. Three payments of A$48.4 million were made on 1 July 2025, 1 October 2025 and 2 January 2026.

For the nine months ended 31 December 2025, the Company did not provide financial or other support to AICF that it was not previously contractually required to provide.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

*Restricted Investments*

AICF invests its excess cash in time deposits, which are classified as held to maturity investments and the carrying value materially approximates the fair value for each investment. The following table represents the investments outstanding as of 31 December 2025:

---

| | | | |
|:---|:---|:---|:---|
| Date Invested | Maturity Date | Interest Rate | A$ Millions |
| October 2025 | 16 October 2026 | 4.14% | 70.0 |
| July 2025 | 24 July 2026 | 4.14% | 60.0 |
| April 2025 | 7 April 2026 | 4.16% | 90.0 |
| January 2025 | 27 January 2026 | 4.87% | 60.0 |

---

**9. Derivative Instruments** 

In May 2025, the Company entered into an interest rate swap agreement to manage interest rate risk related to the Company's Term Facilities by swapping variable interest at a rate based on SOFR with a fixed rate of 3.79%. The interest rate swap agreement has a notional amount of US$1.0 billion and will expire on 30 June 2028.

On 1 July 2025, the Company met the requirements to designate the swap as a cash flow hedge. The fair value of the interest rate swap is estimated by using a valuation model based on observable market data, including yield curves. The gain (loss) is recorded in *Accumulated other comprehensive loss* and then reclassified into *Interest, net* in the same period in which the hedged transaction affects earnings. As of 31 December 2025, the Company expects to reclass approximately US$7.9 million (US$5.9 million after-tax) as a decrease to interest expense in the next 12 months.

For the three months ended 30 June 2025, the swap did not meet the requirements for hedge designation and the Company recorded a loss of US$11.6 million in *Other expense (income), net*.

The fair value of the interest rate swap and classification on the condensed consolidated balance sheets is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Fair Value as of** | **Fair Value as of** |
|<br>(Millions of US dollars) |<br>**Fair Value Hierarchy** |<br>**Balance Sheet Location** | **31 December 2025** | **31 March 2025** |
| Interest rate swap | Level 2 | Other current liabilities | $12.2 | $— |

---

Refer to Note 13 "Accumulated Other Comprehensive Loss" for further details of the effect derivative instruments.

**10. Commitments and Contingencies**

<u>Legal Matters</u>

The Company is involved from time to time in various legal proceedings and administrative actions related to the normal conduct of its business, including general liability claims, putative class action lawsuits and litigation concerning its products.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

Although it is impossible to predict the outcome of any pending legal proceeding, management believes that such proceedings and actions should not, individually or in the aggregate, have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows, except as described in these condensed consolidated financial statements.

<u>Australia Class Action Securities Claim</u>

On 8 May 2023, a group proceeding (class action) was filed in The Supreme Court of Victoria, Australia by Raeken Pty Ltd against James Hardie Industries plc on behalf of persons who purchased certain James Hardie equity securities from 7 February 2022 through 7 November 2022. The litigation is being funded by a litigation funder in Australia, CASL Funder Pty Ltd. The proceeding includes allegations that James Hardie breached relevant provisions of the Corporations Act 2001 (Cth) and the Australian and Securities Investment Act 2001 (Cth), including with respect to certain forward-looking statements James Hardie made about forecasted financial performance measures during the period specified above. The Company believes the challenged statements were proper and is defending the matter. Currently, the Plaintiffs are seeking leave to amend their statement of claim for a second time, and, as a result the July 2026 trial date has been vacated with no new trial date set. As of 31 December 2025, the Company has not recorded a reserve related to this matter as the chance of loss is not probable and the amount of loss, if any, cannot be reasonably estimated.

<u>Australian Tax Office ("ATO") Audit</u>

In February 2024, the ATO issued a transfer pricing position paper for income years ended 31 March 2011 through 31 March 2019, setting out the ATO's view that certain profits related to arrangements with the Company's technology holding company based in Ireland should be allocated to Australian subsidiaries of the Company and taxed in Australia. In October 2025, the Company and the ATO reached an agreement which finalized the tax audit being conducted by the ATO on the Company's Australian income tax returns for the years ended 31 March 2011 through 31 March 2019, settled all outstanding issues arising from this audit up to and including the year ended 31 March 2025, and provides greater clarity for future years. The agreed settlement was made without concessions or admissions of liability by either the Company or the ATO. During the nine months ended 31 December 2025, the Company recognized an income tax expense of US$18.2 million (A$27.6 million) and a corresponding non-cash reduction in the deferred tax assets relating to Australian net operating losses in respect of this settlement. There will be no additional taxes payable in respect of this settlement.

<u>U.S. Class Action Securities Claim</u>

On 24 October 2025, a putative class action was filed in United Stated District Court for the Northern District of Illinois by Laborers' District Council and Contractors' Pension Fund of Ohio against James Hardie Industries plc and its CEO and CFO on behalf of persons who purchased certain James Hardie equity securities from 20 May 2025 through 18 August 2025.

The proceeding includes allegations that James Hardie violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b) and 78t(a) and Rule 10b-5 promulgated thereunder by the SEC, 17 C.F.R. § 240.10 b-5., including regarding its knowledge of customers destocking inventory in April and early May 2025 and statements on 20 and 21 May 2025 about inventory destocking occurring. The Company believes the challenged statements were proper and is defending the matter. The Company has not recorded a reserve related to this matter as the chance of loss is not probable and the amount of loss, if any, cannot be reasonably estimated.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

<u>Environmental</u>

The operations of the Company, like those of other companies engaged in similar businesses, are subject to a number of laws and regulations on air, soil and water quality, waste handling and disposal. The Company's policy is to accrue for environmental costs when it is determined that it is probable that an obligation exists and the amount can be reasonably estimated.

**11. Income Taxes**

*Income taxes payable* represents taxes currently payable which are computed at statutory income tax rates applicable to taxable income derived in each jurisdiction in which the Company conducts business. During the nine months ended 31 December 2025, the Company paid taxes, net of refunds, of US$71.2 million.

*Income tax expense* differs from the statutory rate primarily due to the Company's mix of pre-tax income by jurisdiction and foreign taxes on domestic income, plus discrete items including the impact of the ATO settlement agreement.

*Deferred income taxes* include net operating loss carry-forwards. At 31 December 2025, the Company had tax loss carry-forwards in Australia, New Zealand, Europe and the US of approximately US$69.1 million that are available to offset future taxable income in the respective jurisdiction. The Company establishes a valuation allowance against a deferred tax asset if it is more likely than not that some portion or all of the deferred tax asset will not be realized.

The Australian tax loss carry-forwards primarily result from current and prior year tax deductions for contributions to AICF. James Hardie 117 Pty Limited, the performing subsidiary under the AFFA, is able to claim a tax deduction for its contributions to AICF over a five-year period commencing in the year the contribution is incurred. At 31 December 2025, the Company recognized a tax deduction of US$94.4 million (A$145.1 million) for the current year relating to total contributions to AICF of US$674.5 million (A$967.5 million) incurred in tax years 2022 through 2026.

On 4 July 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted in the U.S. The OBBBA includes significant provisions, including reinstatement of federal bonus depreciation, deductions for domestic research and development expenditures, and modifications to the international tax framework. The enactment of OBBBA did not have a material impact on the Company's condensed consolidated financial statements.

**12. Stock-Based Compensation**

Total stock-based compensation expense consists of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 | **2025** | 2024 |
| Liability Awards | $**2.9** | $(0.4) | $**8.4** | $3.0 |
| Equity Awards | **8.8** | 5.4 | **28.4** | 17.7 |
| **Total stock-based compensation expense** | $**11.7** | $5.0 | $**36.8** | $20.7 |

---

Total stock-based compensation expense for the nine months ended 31 December 2025 includes replacement awards issued in connection with the AZEK merger.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

As of 31 December 2025, the unrecorded future stock-based compensation expense related to outstanding equity awards was US$64.0 million and will be recognized over an estimated weighted average amortization period of 2.0 years.

As of the acquisition date, the estimated fair value of the assumed equity awards was US$182.1 million, of which US$160.0 million was recognized as goodwill and the balance of US$22.1 million will be recognized as stock-based compensation expense over the remainder term of the replacement awards. The fair value of the replacement awards for services rendered through the acquisition date was recognized as a component of the purchase consideration, with the remaining fair value related to the post-combination services to be recorded as stock-based compensation over the remaining vesting period.

The Company used the Black-Scholes pricing model to estimate the fair value of replacement service-based stock option awards. The significant assumptions used for the stock option valuation include risk free interest rate of 3.75% - 3.88%, expected volatility of 35.0% - 40.0%, expected terms of 2.47 - 5.60 years, and expected dividend yield of 0.0%. The fair value of the replacement restricted stock units was based on the closing price on the acquisition date.

**13. Accumulated Other Comprehensive Loss**

*Accumulated other comprehensive loss* consists of the following at 31 December 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (Millions of US dollars) | Cash Flow<br>Hedges | Pension<br>Actuarial<br>Gain | Foreign<br>Currency<br>Translation<br>Adjustments | Total |
| Balance at 31 March 2025 | $0.1 | $1.4 | $(59.7) | $(58.2) |
| Change in component, net of tax | (0.8) |  | 20.6 | 19.8 |
| Reclassification from other comprehensive loss into net income, net of tax | (0.8) |  |  | (0.8) |
| **Balance at 31 December 2025** | $**(1.5)** | $**1.4** | $**(39.1)** | $**(39.2)** |

---

**14. Restructuring, net**

*Restructuring, net* consists of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 | **2025** | 2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equipment write offs, including disposal costs | $**—** | $— | $**—** | $31.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of foreign currency translation adjustments | **—** |  | **—** | 8.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other exit costs | **—** |  | **—** | 17.9 |
| **Australia & New Zealand segment** | **—** |  | **—** | 57.3 |
| **Deck, Rail & Accessories segment** | **2.2** |  | **2.2** |  |
| **General Corporate** | **(26.2)** |  | **(26.2)** |  |
| **Total** | $**(24.0)** | $— | $**(24.0)** | $57.3 |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

*Australia & New Zealand segment*

For the nine months ended 31 December 2024, the Company recorded US$57.3 million of exit costs related to its decision to shut down its manufacturing and wind-down commercial operations in the Philippines. The net assets remaining in the Philippines primarily consists of land and buildings, which the Company is actively marketing to sell.

*General Corporate*

During the three months ended 31 December 2025, the Company completed the sale of its Truganina greenfield site and received proceeds of US$108.2 million and recorded a gain on sale of US$26.2 million in General Corporate Costs.

**15. Segment Information** 

As of 31 December 2025, the Company has four reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Siding & Trim segment - Manufactures fiber cement and PVC exterior siding and trim products, as well as moulding, interior linings, and accessories in the United States. These products are sold in the United States and Canada.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Deck, Rail & Accessories segment - Manufactures decking, railing, cladding, pergolas, cabanas and related accessories in the United States; these products are sold in the United States and Canada.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Australia & New Zealand segment - Includes fiber cement products manufactured in Australia and sold in Australia and New Zealand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Europe segment - Includes fiber gypsum products and cement bonded boards manufactured in Europe, and fiber cement products manufactured in the United States that are sold in Europe.

The Company's General Corporate and unallocated Research and Development ("R&D") costs do not meet the applicable accounting guidance for separate disclosure as a reportable segment, and are reflected as reconciling items to consolidated *Operating Income*. General Corporate costs primarily consist of *Asbestos adjustments*, officer and employee compensation and related benefits, professional and legal fees, administrative costs, acquisition related costs and rental expense on the Company's corporate offices, which are not allocated to the reportable segments. Unallocated R&D costs represented the costs incurred by the research and development centers which were costs not directly associated with one of our reportable segments. Beginning 1 July 2025, R&D costs are allocated to the segments. For the three months ended 31 December 2025, US$8.8 million was allocated to Siding & Trim, US$1.3 million to Australia & New Zealand and US$0.2 million to Europe. For the nine months ended 31 December 2025, US$16.5 million was allocated to Siding & Trim, US$2.5 million to Australia & New Zealand and US$0.4 million to Europe. The Company does not report total assets by segment as the Company's Chief Operating Decision Maker does not assess performance, or allocate resources based on segment assets.

The Company does not report *Interest, net* for each segment as the segments are not held directly accountable for interest.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

The following is the Company's segment information:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Operating Income | Operating Income | Operating Income | Operating Income | Operating Income |
| (Millions of US dollars) | Siding &<br>Trim | Deck, Rail & Accessories | Australia & New Zealand | Europe | Total |
| *For the three months ended 31 December 2025* | *For the three months ended 31 December 2025* |  |  |  |  |
| &nbsp;&nbsp;Net sales | $788.3 | $194.1 | $126.5 | $130.9 | $1239.8 |
| &nbsp;&nbsp;Cost of goods sold | 481.2 | 143.8 | 75.0 | 91.6 | 791.6 |
| &nbsp;&nbsp;Gross profit | 307.1 | 50.3 | 51.5 | 39.3 | 448.2 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 89.3 | 69.7 | 14.3 | 29.1 | 202.4 |
| &nbsp;&nbsp;Restructuring expense |  | 2.2 |  |  | 2.2 |
| &nbsp;&nbsp;Other expenses <sup>1</sup> | 14.9 | 2.4 | 1.6 | 1.1 | 20.0 |
| &nbsp;&nbsp;Segment operating income (loss) | $202.9 | $(24.0) | $35.6 | $9.1 | $223.6 |
| &nbsp;&nbsp;Reconciliation to consolidated operating income |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Less: General Corporate <sup>2, 3</sup> |  |  |  |  | (47.4) |
| &nbsp;&nbsp;Consolidated operating income |  |  |  |  | $176.2 |
| *For the nine months ended 31 December 2025* | *For the nine months ended 31 December 2025* |  |  |  |  |
| &nbsp;&nbsp;Net sales | $2196.1 | $449.9 | $381.0 | $404.9 | $3431.9 |
| &nbsp;&nbsp;Cost of goods sold | 1382.2 | 343.8 | 220.6 | 279.1 | 2225.7 |
| &nbsp;&nbsp;Gross profit | 813.9 | 106.1 | 160.4 | 125.8 | 1206.2 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 265.9 | 134.9 | 45.6 | 85.1 | 531.5 |
| &nbsp;&nbsp;Restructuring expense |  | 2.2 |  |  | 2.2 |
| &nbsp;&nbsp;Other expenses <sup>1</sup> | 32.9 | 4.9 | 3.4 | 2.8 | 44.0 |
| &nbsp;&nbsp;Segment operating income (loss) | $515.1 | $(35.9) | $111.4 | $37.9 | $628.5 |
| &nbsp;&nbsp;Reconciliation to consolidated operating income |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Less: General Corporate and Unallocated R&D <sup>2, 3</sup> |  |  |  |  | (289.7) |
| &nbsp;&nbsp;Consolidated operating income |  |  |  |  | $338.8 |

---

**____________**

1. Other expenses represent R&D costs and acquisition related expenses allocated to the segments.

2. Includes acquisition related expenses.

3. Starting 1 July 2025, the Company began allocating R&D costs to the segments.

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Operating Income | Operating Income | Operating Income | Operating Income |
| (Millions of US dollars) | Siding &<br>Trim | Australia & New Zealand | Europe | Total |
| *For the three months ended 31 December 2024* | *For the three months ended 31 December 2024* |  |  |  |
| &nbsp;&nbsp;Net sales | $719.3 | $118.1 | $115.9 | $953.3 |
| &nbsp;&nbsp;Cost of goods sold | 435.5 | 68.9 | 86.5 | 590.9 |
| &nbsp;&nbsp;Gross profit | 283.8 | 49.2 | 29.4 | 362.4 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 72.7 | 14.0 | 25.1 | 111.8 |
| &nbsp;&nbsp;Other expenses <sup>1</sup> | 1.8 | 0.4 | 0.7 | 2.9 |
| &nbsp;&nbsp;Segment operating income | $209.3 | $34.8 | $3.6 | $247.7 |
| &nbsp;&nbsp;Reconciliation to consolidated operating income |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Less: General Corporate and Unallocated R&D costs |  |  |  | (41.6) |
| &nbsp;&nbsp;Consolidated operating income |  |  |  | $206.1 |
| *For the nine months ended 31 December 2024* | *For the nine months ended 31 December 2024* |  |  |  |
| &nbsp;&nbsp;Net sales | $2144.4 | $401.8 | $359.8 | $2906 |
| &nbsp;&nbsp;Cost of goods sold | 1281.2 | 233.4 | 259.2 | 1773.8 |
| &nbsp;&nbsp;Gross profit | 863.2 | 168.4 | 100.6 | 1132.2 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 217.6 | 42.1 | 74.1 | 333.8 |
| &nbsp;&nbsp;Restructuring expenses |  | 57.3 |  | 57.3 |
| &nbsp;&nbsp;Other expenses <sup>1</sup> | 7.1 | 1.0 | 1.8 | 9.9 |
| &nbsp;&nbsp;Segment operating income | $638.5 | $68.0 | $24.7 | $731.2 |
| &nbsp;&nbsp;Reconciliation to consolidated operating income |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Less: General Corporate and Unallocated R&D costs |  |  |  | (137.4) |
| &nbsp;&nbsp;Consolidated operating income |  |  |  | $593.8 |

---

**____________**

1. Other expenses represent R&D costs allocated to the segments.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Depreciation and Amortization | Depreciation and Amortization | Depreciation and Amortization | Depreciation and Amortization |
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars) | **2025** | 2024 | **2025** | 2024 |
| Siding & Trim | $**62.1** | $41.2 | $**163.7** | $115.5 |
| Deck, Rail & Accessories | **70.5** |  | **124.3** |  |
| Australia & New Zealand | **5.6** | 4.9 | **16.3** | 14.4 |
| Europe | **7.5** | 8.3 | **21.6** | 23.9 |
| General Corporate and R&D | **1.9** | 0.7 | **4.6** | 3.0 |
| Total | $**147.6** | $55.1 | $**330.5** | $156.8 |

---

------

**James Hardie Industries plc**

**Notes to Condensed Consolidated Financial Statements (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Capital Expenditures | Capital Expenditures | Capital Expenditures | Capital Expenditures |
| | Three Months<br>Ended 31 December | Three Months<br>Ended 31 December | Nine Months<br>Ended 31 December | Nine Months<br>Ended 31 December |
| (Millions of US dollars) | **2025** | **2024** | **2025** | 2024 |
| Siding & Trim | $**48.0** | $62.4 | $**175.6** | $216.4 |
| Deck, Rail & Accessories | **18.3** |  | **34.4** |  |
| Australia & New Zealand | **25.2** | 19.0 | **51.5** | 44.0 |
| Europe | **13.1** | 23.8 | **33.9** | 67.7 |
| General Corporate and R&D | **2.3** | 2.6 | **7.4** | 4.9 |
| Total | $**106.9** | $107.8 | $**302.8** | $333.0 |

---

**16. Subsequent Event**

On 15 January 2026, the Company announced that it is optimizing its manufacturing footprint in the United States and will close the Company's manufacturing facilities in Fontana, California and Summerville, South Carolina within 60 days from the announcement.

The Company expects to incur one-time pre-tax charges of approximately US$40.0 million to US$44.0 million in connection with the site closures and optimization actions. These charges are expected to consist primarily of employee severance, benefits and transition-related costs, contract termination, and facility exit costs, as well as asset impairments and other non-cash charges. The one-time pre-tax charges are expected to be recognized primarily in the fourth quarter of fiscal year 2026, split approximately evenly between cash and non-cash items.

## Exhibit 99.6

![](ex996statementofcdisonis001.jpg)

Appendix 4A - Statement of CDIs on issue Appendix 4A - Statement of CDIs on issue 1 / 2 Part 1 - Entity and announcement details 1.1 Name of +Entity JAMES HARDIE INDUSTRIES PLC 1.2 Registered Number Type ARBN Registration Number 097829895 1.3 ASX issuer code JHX 1.4 The announcement is 1.5 Date of this announcement 5/2/2026 New announcement

------

![](ex996statementofcdisonis002.jpg)

Appendix 4A - Statement of CDIs on issue Appendix 4A - Statement of CDIs on issue 2 / 2 Part 2 - Details of +CDIs and other +securities on issue 2.1 Statement for month and year January-2026 2.2a Number and class of all +CDIs issued over quoted +securities ASX Security Code and Description JHX : CHESS DEPOSITARY INTERESTS 1:1 +CDI Ratio 1:1 Total number of +CDIs issued over quoted +securities at end of statement month (A): 430,436,032 Total number of +CDIs issued over quoted +securities at end of previous month (B): 430,436,032 Net Difference (A-B) 0 If the total number of +CDIs issued over quoted +securities at the end of the statement month, is greater than the total number of +CDIs issued over quoted +securities for which the entity has previously paid an initial listing fee or an additional listing fee under Table 1A and 1C of Guidance Note 15A, the entity hereby applies for +quotation of the relevant securities and agrees to the matters set out in Appendix 2A of the ASX Listing Rules. 2.2b Number and class of all +securities on issue over which +CDIs have not been issued ASX Security Code and Description JHXAM : ORDINARY SHARES Total number of +securities at end of statement month (A) 149,626,141 Total number of +securities at end of previous month (B) 149,626,141 Net Difference (A-B) 0 ASX Security Code and Description JHXAK : RESTRICTED STOCK UNIT Total number of +securities at end of statement month (A) 5,415,537 Total number of +securities at end of previous month (B) 5,415,537 Net Difference (A-B) 0 ASX Security Code and Description JHXAL : OPTION EXPIRING 03-NOV-2027 EX $33.05 Total number of +securities at end of statement month (A) 269,221 Total number of +securities at end of previous month (B) 269,221 Net Difference (A-B) 0

------

## Exhibit 99.7

![](ex997notificationregardi001.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 5 Announcement Summary Entity name JAMES HARDIE INDUSTRIES PLC Date of this announcement Saturday February 07, 2026 The +securities the subject of this notification are: Total number of +securities to be issued/transferred ASX +security code Security description Total number of +securities to be issued/transferred Issue date JHXAM ORDINARY SHARES 35,378 02/02/2026 Refer to next page for full details of the announcement +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX

------

![](ex997notificationregardi002.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 2 / 5 Part 1 - Entity and announcement details 1.1 Name of entity JAMES HARDIE INDUSTRIES PLC We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type ARBN Registration number 097829895 1.3 ASX issuer code JHX 1.4 The announcement is 1.5 Date of this announcement 7/2/2026 New announcement

------

![](ex997notificationregardi003.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 3 / 5 Part 2 - Issue details 2.1 The +securities the subject of this notification are: Previous Appendix 3B details: Announcement Date and Time 24-Mar-2025 08:33 Announcement Title New - Proposed issue of securities - JHX Selected Appendix 3B to submit quotation request A placement or other type of issue 2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? 2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B On July 1, 2025, James Hardie Industries plc ("James Hardie") consummated the merger contemplated by the Agreement and Plan of Merger, dated as of March 23, 2025, as amended, by and among James Hardie, Juno Merger Sub Inc., and The AZEK Company Inc. ("AZEK"). Shares issued represent James Hardie ordinary shares issued in respect of the settlement of certain AZEK equity awards outstanding as of the closing of the merger. Yes +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX

------

![](ex997notificationregardi004.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 4 / 5 Part 3A - number and type of +securities the subject of this notification (existing class or new class) where issue has previously been notified to ASX in an Appendix 3B Placement Details ASX +security code and description JHXAM : ORDINARY SHARES Date the +securities the subject of this notification were issued 2/2/2026 Any other information the entity wishes to provide about the +securities the subject of this notification James Hardie Industries plc applied for a waiver from Listing Rule 2.4 in respect to the issuance of the unquoted securities described in this appendix on 7 July 2025. ASX granted the waiver on 16 July 2025. Issue details Number of +securities 35,378 Were the +securities issued for a cash consideration? In what currency was the cash consideration being paid? USD - US Dollar What was the issue price per +security? USD 0.69920000 Yes

------

![](ex997notificationregardi005.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 5 / 5 Part 4 - +Securities on issue Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX) ASX +security code and description Total number of +securities on issue JHX : CHESS DEPOSITARY INTERESTS 1:1 430,436,032 4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue JHXAK : RESTRICTED STOCK UNIT 5,415,537 JHXAM : ORDINARY SHARES 149,661,519 JHXAL : OPTION EXPIRING 03-NOV-2027 EX $33.05 269,221

------

## Exhibit 99.8

![](ex998notificationregardi001.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 6 Announcement Summary Entity name JAMES HARDIE INDUSTRIES PLC Date of this announcement Saturday February 07, 2026 The +securities the subject of this notification are: Total number of +securities to be issued/transferred ASX +security code Security description Total number of +securities to be issued/transferred Issue date JHXAK RESTRICTED STOCK UNIT 15,365 02/02/2026 Refer to next page for full details of the announcement +Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

------

![](ex998notificationregardi002.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 2 / 6 Part 1 - Entity and announcement details 1.1 Name of entity JAMES HARDIE INDUSTRIES PLC We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type ARBN Registration number 097829895 1.3 ASX issuer code JHX 1.4 The announcement is 1.5 Date of this announcement 7/2/2026 New announcement

------

![](ex998notificationregardi003.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 3 / 6 Part 2 - Issue details 2.1 The +securities the subject of this notification are: 2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which: has an existing ASX security code ("existing class") +Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

------

![](ex998notificationregardi004.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 4 / 6 Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B Additional +securities in an existing class issued under an +employee incentive scheme ASX +security code and description JHXAK : RESTRICTED STOCK UNIT Date the +securities the subject of this notification were issued 2/2/2026 Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class Were any of the +securities issued to +key management personnel (KMP) or an +associate? Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms Refer to the 2001 Plan: https://ir.jameshardie.com.au/public/download.jsp?id=5562 Any other information the entity wishes to provide about the +securities the subject of this notification Grant of 15,365 Restricted Stock Units (RSUs) granted under the James Hardie Industries Equity Incentive Plan 2001 (2001 Plan). Issue details Number of +securities 15,365 No Yes

------

![](ex998notificationregardi005.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 5 / 6 Part 4 - +Securities on issue Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX) ASX +security code and description Total number of +securities on issue JHX : CHESS DEPOSITARY INTERESTS 1:1 430,436,032 4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue JHXAK : RESTRICTED STOCK UNIT 5,430,902 JHXAM : ORDINARY SHARES 149,626,141 JHXAL : OPTION EXPIRING 03-NOV-2027 EX $33.05 269,221

------

![](ex998notificationregardi006.jpg)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 6 / 6 Part 5 - Other Listing Rule requirements 5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? 5.1a Select the number of the applicable exception in Listing Rule 7.2 13 Yes

------